<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8"/>
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0"/>
  <title>Micra‚Ñ¢ PMA Live Dashboard ¬∑ P150033</title>
  <style>
    *,*::before,*::after{box-sizing:border-box;margin:0;padding:0}
    html,body{width:100%;min-height:100vh;background:#050505;font-family:'Georgia',serif;color:#e2e8f0}
    a{color:#A100FF;text-decoration:none}a:hover{text-decoration:underline}
    button{cursor:pointer;font-family:inherit;border:none;background:none}
    table{border-collapse:collapse;width:100%}
    .wrap{width:100%;padding:32px 4%}

    /* Header */
    .hdr{border-bottom:1px solid #2D0066;padding-bottom:24px;margin-bottom:32px;display:flex;justify-content:space-between;flex-wrap:wrap;gap:16px;align-items:flex-start}
    .hdr-meta{font-size:11px;letter-spacing:.2em;color:#A100FF;text-transform:uppercase;margin-bottom:8px;font-family:monospace}
    .hdr h1{font-size:clamp(20px,2.4vw,27px);font-weight:700;color:#f8fafc;line-height:1.2}
    .hdr h2{font-size:clamp(13px,1.4vw,16px);font-weight:400;color:#94a3b8;margin-top:6px}
    .hdr-right{text-align:right}
    .hdr-right .lbl{font-size:11px;color:#64748b;letter-spacing:.1em;text-transform:uppercase}
    .hdr-right .date{font-size:clamp(16px,2vw,22px);font-weight:700;color:#A100FF}
    .hdr-right .sub{font-size:12px;color:#64748b}
    .live-badge{display:inline-flex;align-items:center;gap:6px;background:#001a0a;border:1px solid #00AA55;border-radius:20px;padding:3px 10px;font-size:10px;color:#00E676;font-family:monospace;margin-top:8px}
    .live-dot{width:6px;height:6px;border-radius:50%;background:#00E676;animation:pulse 1.5s infinite}
    @keyframes pulse{0%,100%{opacity:1}50%{opacity:.3}}

    .sec-lbl{font-size:13px;color:#A100FF;letter-spacing:.12em;text-transform:uppercase;font-family:monospace}

    /* KPI Cards */
    .kpi-grid{display:grid;grid-template-columns:repeat(5,1fr);gap:12px;margin:16px 0 32px}
    .kpi-card{background:#0f0f0f;border-radius:10px;padding:18px 14px;text-align:left;transition:all .15s;color:inherit;border:1px solid #1a1a1a}
    .kpi-card:hover{filter:brightness(1.12)}
    .kpi-icon{font-size:22px;margin-bottom:10px}
    .kpi-count{font-size:32px;font-weight:700;line-height:1}
    .kpi-pct{font-size:10px;color:#64748b;margin-top:3px}
    .kpi-name{font-size:11px;color:#94a3b8;margin-top:8px;line-height:1.4}

    /* Bar Chart ‚Äî Horizontal HCC-style */
    .chart-box{background:#0f0f0f;border:1px solid #1a1a1a;border-radius:12px;padding:28px 24px;margin-bottom:40px}
    .bar-wrap{display:flex;flex-direction:column;gap:0}
    .bar-col{display:grid;grid-template-columns:200px 1fr;border-bottom:1px solid #161616;transition:background .15s;cursor:pointer}
    .bar-col:last-child{border-bottom:none}
    .bar-col:hover{background:rgba(255,255,255,.015)}
    .bar-col.selected{background:rgba(255,255,255,.025)}
    .bar-val{font-size:13px;font-weight:700;margin-bottom:0}
    .bar-label-col{padding:18px 16px 18px 0;display:flex;flex-direction:column;justify-content:center;border-right:1px solid #1a1a1a;position:relative}
    .bar-label-col::after{content:'';position:absolute;right:-1px;top:25%;height:50%;width:2px;opacity:.4;border-radius:1px}
    .bar-name{font-size:14px;font-weight:700;color:#e8e8e8;letter-spacing:.02em;line-height:1.2;margin-bottom:3px}
    .bar-sub{font-family:monospace;font-size:9px;color:#444;letter-spacing:.1em;text-transform:uppercase}
    .bar-track-col{padding:16px 0 16px 28px;display:flex;flex-direction:column;justify-content:center;gap:6px}
    .bar-track{flex:1;height:30px;background:rgba(255,255,255,.03);border-radius:4px;position:relative;border:1px solid rgba(255,255,255,.04);overflow:visible}
    .bar-h{height:100%;border-radius:4px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1);position:relative;overflow:visible}
    .bar-bubble{position:absolute;right:-14px;top:50%;transform:translateY(-50%);background:#141414;border:1px solid;border-radius:20px;padding:2px 10px;font-family:monospace;font-size:11px;font-weight:700;white-space:nowrap;z-index:5}
    .bar-pct{font-family:monospace;font-size:9px;color:#444;margin-left:0;margin-top:2px;letter-spacing:.08em}

    /* Detail panel (top section click) */
    .detail-panel{border-radius:12px;padding:28px;margin-bottom:32px}
    .d-hdr{display:flex;align-items:center;gap:12px;margin-bottom:16px;flex-wrap:wrap}
    .d-icon{font-size:24px}
    .d-title{font-size:18px;font-weight:700}
    .d-type{font-size:12px;color:#64748b;margin-top:2px}
    .d-count{margin-left:auto;text-align:right;font-size:32px;font-weight:700}
    .d-pct{font-size:12px;color:#64748b}
    .d-desc{font-size:13px;color:#94a3b8;line-height:1.6;margin-bottom:12px}

    /* Three Tiers */
    .tiers-grid{display:grid;grid-template-columns:repeat(3,1fr);gap:16px;margin:16px 0 40px}
    .tier-card{border-radius:12px;padding:22px;border:1px solid}
    .tier-num{font-size:10px;letter-spacing:.15em;text-transform:uppercase;font-family:monospace;margin-bottom:6px}
    .tier-title{font-size:16px;font-weight:700;margin-bottom:4px}
    .tier-date{font-size:12px;margin-bottom:10px;opacity:.8}
    .tier-desc{font-size:12px;line-height:1.7;color:#94a3b8}
    .tier-desc strong{color:#e2e8f0}

    /* Section 3 expandable table */
    .table-box{background:#0f0f0f;border:1px solid #1a1a1a;border-radius:12px;padding:28px;margin-bottom:32px}
    th{padding:9px 12px;text-align:left;color:#475569;font-weight:600;letter-spacing:.05em;text-transform:uppercase;font-size:10px;border-bottom:1px solid #1a1a1a;white-space:nowrap}
    td{padding:10px 12px;color:#cbd5e1;line-height:1.5;font-size:12px}
    .s-th{color:#A100FF;font-size:11px;letter-spacing:.08em;border-bottom:2px solid #2D0066;padding:10px 14px}
    .s-td{padding:12px 14px;font-size:13px}

    /* Clickable summary row */
    .sum-row{cursor:pointer;transition:background .15s;border-bottom:1px solid #1a1a1a}
    .sum-row:hover{filter:brightness(1.2)}
    .expand-arrow{font-size:12px;transition:transform .2s;display:inline-block;margin-right:6px;color:#64748b}
    .expand-arrow.open{transform:rotate(90deg);color:#A100FF}

    /* Expanded dropdown row */
    .expand-row{display:none;border-bottom:1px solid #1a1a1a}
    .expand-row.open{display:table-row}
    .expand-inner{padding:0 0 0 0;background:#050505}

    /* Inner expanded content */
    .exp-box{padding:20px 24px;border-top:1px solid #0d0d0d}
    .exp-header{display:flex;align-items:center;gap:12px;margin-bottom:14px;flex-wrap:wrap}
    .exp-desc{font-size:12px;color:#94a3b8;line-height:1.6;margin-bottom:16px;max-width:800px}
    .exp-count-badge{background:var(--ec);color:#fff;border-radius:6px;padding:4px 14px;font-size:13px;font-weight:700;font-family:monospace}
    .exp-table th{background:#0f0f0f;font-size:10px;color:#475569;padding:7px 10px}
    .exp-table td{padding:8px 10px;font-size:11px;border-bottom:1px solid #0d1a2e}
    .exp-table tr:last-child td{border-bottom:none}

    /* Live supplements sub-table */
    .live-sub{margin-top:16px}
    .live-sub-lbl{font-size:10px;letter-spacing:.15em;text-transform:uppercase;font-family:monospace;color:#334155;margin-bottom:8px}
    .live-status{font-size:11px;color:#475569;font-family:monospace;padding:8px 0}

    /* Prog bar */
    .prog-wrap{display:flex;align-items:center;gap:8px}
    .prog-track{width:60px;height:6px;background:#1a1a1a;border-radius:3px;overflow:hidden}
    .prog-fill{height:100%;border-radius:3px}

    /* Section 4 */
    .filter-bar{display:flex;gap:8px;flex-wrap:wrap;margin-bottom:16px}
    .fbtn{padding:4px 12px;border-radius:20px;font-size:11px;font-family:monospace;cursor:pointer;transition:all .15s}
    .badge{display:inline-block;padding:2px 8px;border-radius:4px;font-size:10px;font-family:monospace;font-weight:600}
    .loading-row{text-align:center;padding:24px;color:#64748b;font-size:12px;font-family:monospace}
    .spinner{display:inline-block;width:16px;height:16px;border:2px solid #1a1a1a;border-top-color:#A100FF;border-radius:50%;animation:spin .8s linear infinite;margin-right:6px;vertical-align:middle}
    @keyframes spin{to{transform:rotate(360deg)}}
    .error-box{background:#1a0a0a;border:1px solid #7f1d1d;border-radius:8px;padding:14px;margin-bottom:16px;color:#fca5a5;font-size:12px}

    .footer{margin-top:20px;font-size:11px;color:#334155;text-align:center;line-height:1.8}

    /* Tab Navigation */
    .tab-nav{display:flex;gap:0;border-bottom:2px solid #2D0066;margin-bottom:32px;flex-wrap:wrap}
    .tab-btn{padding:10px 24px;font-size:12px;letter-spacing:.1em;text-transform:uppercase;font-family:monospace;color:#475569;border:none;background:none;cursor:pointer;border-bottom:3px solid transparent;margin-bottom:-2px;transition:all .2s}
    .tab-btn:hover{color:#94a3b8}
    .tab-btn.active{color:#CC33FF;border-bottom-color:#CC33FF;font-weight:700}
    .tab-panel{display:none}
    .tab-panel.active{display:block}

    /* Competitor tab */
    .comp-metric-grid{display:grid;grid-template-columns:repeat(3,1fr);gap:16px;margin:16px 0 32px}
    .comp-card{background:#0f0f0f;border:1px solid #1a1a1a;border-radius:12px;padding:20px}
    .comp-card-hdr{display:flex;align-items:center;gap:10px;margin-bottom:14px;padding-bottom:12px;border-bottom:1px solid #1a1a1a}
    .comp-logo{width:36px;height:36px;border-radius:6px;display:flex;align-items:center;justify-content:center;font-size:11px;font-weight:700;font-family:monospace;flex-shrink:0}
    .comp-name{font-size:13px;font-weight:700;color:#f1f5f9}
    .comp-product{font-size:10px;color:#64748b;margin-top:2px}
    .comp-row{display:flex;justify-content:space-between;align-items:flex-start;padding:5px 0;border-bottom:1px solid #111111;gap:12px}
    .comp-row:last-child{border-bottom:none}
    .comp-key{font-size:10px;color:#64748b;font-family:monospace;flex-shrink:0}
    .comp-val{font-size:11px;color:#cbd5e1;text-align:right;line-height:1.4}

    /* SVG donut charts */
    .donut-grid{display:grid;grid-template-columns:repeat(3,1fr);gap:16px;margin:16px 0 32px}
    .donut-card{background:#0f0f0f;border:1px solid #1a1a1a;border-radius:12px;padding:20px;text-align:center}
    .donut-title{font-size:11px;color:#A100FF;font-family:monospace;letter-spacing:.1em;text-transform:uppercase;margin-bottom:16px}
    .donut-wrap{position:relative;display:inline-block;width:140px;height:140px}
    .donut-center{position:absolute;top:50%;left:50%;transform:translate(-50%,-50%);text-align:center}
    .donut-num{font-size:22px;font-weight:700}
    .donut-sub{font-size:9px;color:#64748b;font-family:monospace;text-transform:uppercase}
    .donut-legend{margin-top:14px;text-align:left}
    .legend-item{display:flex;align-items:center;gap:8px;margin-bottom:5px;font-size:10px;color:#94a3b8}
    .legend-dot{width:8px;height:8px;border-radius:50%;flex-shrink:0}

    /* Comparison bar chart */
    .comp-bar-grid{display:grid;grid-template-columns:1fr 1fr 1fr;gap:12px;align-items:end;height:220px;padding:0 8px 44px;border-left:1px solid #1a1a1a;border-bottom:1px solid #1a1a1a;margin:16px 0 32px}
    .comp-bar-col{display:flex;flex-direction:column;align-items:center;justify-content:flex-end;height:100%;position:relative}
    .comp-bar-val{font-size:16px;font-weight:700;margin-bottom:6px}
    .comp-bar-rect{width:70%;max-width:80px;border-radius:6px 6px 0 0}
    .comp-bar-lbl{position:absolute;bottom:-40px;font-size:10px;color:#64748b;text-align:center;width:130%;line-height:1.4}

    /* Abbott category table */
    .abb-cat-grid{display:grid;grid-template-columns:repeat(5,1fr);gap:10px;margin:16px 0 24px}
    .abb-cat-card{background:#0f0f0f;border:1px solid #1a1a1a;border-radius:8px;padding:14px 10px;text-align:center}

    .status-badge{display:inline-block;padding:3px 10px;border-radius:12px;font-size:10px;font-family:monospace;font-weight:600}

    /* ‚îÄ‚îÄ Horizontal Comparison Chart ‚îÄ‚îÄ */
    .hcc-wrap{background:#0f0f0f;border:1px solid #1a1a1a;border-radius:12px;padding:28px 24px;margin-bottom:32px}
    .hcc-legend{display:flex;gap:28px;margin-bottom:6px;flex-wrap:wrap}
    .hcc-legend-item{display:flex;align-items:center;gap:9px;font-size:11px;font-family:monospace;letter-spacing:.1em;color:#666}
    .hcc-legend-swatch{width:12px;height:12px;border-radius:2px;flex-shrink:0}
    .hcc-legend-name{font-weight:700;font-size:12px}
    .hcc-divider{height:1px;background:linear-gradient(90deg,#A100FF,#00BEFF);opacity:.3;margin:14px 0 24px}
    .hcc-metric-block{display:grid;grid-template-columns:200px 1fr;border-bottom:1px solid #161616;transition:background .2s}
    .hcc-metric-block:last-child{border-bottom:none}
    .hcc-metric-block:hover{background:rgba(255,255,255,.012)}
    .hcc-label-col{padding:22px 18px 22px 0;display:flex;flex-direction:column;justify-content:center;border-right:1px solid #1a1a1a;position:relative}
    .hcc-label-col::after{content:'';position:absolute;right:-1px;top:25%;height:50%;width:2px;background:#A100FF;opacity:.35;border-radius:1px}
    .hcc-metric-num{font-family:monospace;font-size:9px;color:#444;letter-spacing:.15em;margin-bottom:4px}
    .hcc-metric-name{font-size:14px;font-weight:700;color:#e8e8e8;letter-spacing:.02em;line-height:1.2;margin-bottom:4px}
    .hcc-metric-unit{font-family:monospace;font-size:9px;color:#444;letter-spacing:.1em;text-transform:uppercase}
    .hcc-bars-col{padding:18px 0 18px 28px;display:flex;flex-direction:column;justify-content:center;gap:12px}
    .hcc-bar-row{display:flex;align-items:center;gap:0}
    .hcc-co-tag{font-family:monospace;font-size:9px;letter-spacing:.12em;text-transform:uppercase;width:56px;flex-shrink:0;opacity:.7}
    .hcc-track{flex:1;height:26px;background:rgba(255,255,255,.03);border-radius:4px;position:relative;border:1px solid rgba(255,255,255,.04);overflow:visible}
    .hcc-fill{height:100%;border-radius:4px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1);position:relative;overflow:visible}
    .hcc-fill.hcc-mdt{background:linear-gradient(90deg,rgba(161,0,255,.12),#A100FF);box-shadow:0 0 10px rgba(161,0,255,.22)}
    .hcc-fill.hcc-abb{background:linear-gradient(90deg,rgba(0,190,255,.10),#00BEFF);box-shadow:0 0 10px rgba(0,190,255,.20)}
    .hcc-bubble{position:absolute;right:-14px;top:50%;transform:translateY(-50%);background:#141414;border:1px solid;border-radius:20px;padding:2px 9px;font-family:monospace;font-size:10px;font-weight:700;white-space:nowrap;z-index:5}
    .hcc-bubble.mdt{color:#A100FF;border-color:#A100FF;box-shadow:0 0 6px rgba(161,0,255,.25)}
    .hcc-bubble.abb{color:#00BEFF;border-color:#00BEFF;box-shadow:0 0 6px rgba(0,190,255,.22)}
    .hcc-delta{font-family:monospace;font-size:9px;color:#444;margin-left:56px;margin-top:3px;display:flex;align-items:center;gap:6px}
    .hcc-ratio{color:#fff;background:rgba(161,0,255,.13);border:1px solid rgba(161,0,255,.28);border-radius:3px;padding:1px 6px;font-size:9px}
    .hcc-insights{display:grid;grid-template-columns:repeat(5,1fr);gap:10px;margin-top:28px;padding-top:22px;border-top:1px solid #161616}
    .hcc-ins-card{background:#0a0a0a;border:1px solid #1a1a1a;border-radius:8px;padding:14px 12px;position:relative;overflow:hidden}
    .hcc-ins-card::before{content:'';position:absolute;top:0;left:0;right:0;height:2px}
    .hcc-ins-card.ic-mdt::before{background:#A100FF}
    .hcc-ins-card.ic-abb::before{background:#00BEFF}
    .hcc-ins-card.ic-neu::before{background:linear-gradient(90deg,#A100FF,#00BEFF)}
    .hcc-ins-lbl{font-family:monospace;font-size:8px;letter-spacing:.18em;color:#444;text-transform:uppercase;margin-bottom:6px}
    .hcc-ins-txt{font-size:10px;color:#777;line-height:1.55}
    .hcc-ins-txt strong{color:#ccc;font-size:11px}
    @media(max-width:700px){.hcc-metric-block{grid-template-columns:1fr}.hcc-label-col{border-right:none;border-bottom:1px solid #1a1a1a;padding:14px 0 10px}.hcc-bars-col{padding:14px 0}.hcc-insights{grid-template-columns:1fr 1fr}}

    @media(max-width:900px){.comp-metric-grid{grid-template-columns:1fr}.donut-grid{grid-template-columns:1fr}.comp-bar-grid{grid-template-columns:1fr 1fr 1fr}}
    @media(max-width:600px){.kpi-grid{grid-template-columns:repeat(2,1fr)}}
  </style>
</head>
<body>
<div class="wrap">

  <!-- TOP BRANDING BAR -->
  <div style="text-align:left;margin-bottom:28px;padding-bottom:24px;border-bottom:1px solid #2D0066">
    <div style="font-size:clamp(18px,2.5vw,26px);font-weight:700;color:#A100FF;letter-spacing:.04em;margin-bottom:8px">
      Advanced Regulatory Intelligence in Real Time
    </div>
    <div style="font-size:11px;letter-spacing:.2em;color:#A100FF;text-transform:uppercase;font-family:monospace;margin-bottom:8px">
      FDA PMA DATABASE ¬∑ P150033 ¬∑ MEDTRONIC, INC.
    </div>
    <div style="font-size:13px;color:#64748b;letter-spacing:.12em;font-family:monospace;margin-top:4px">
      P4 / <a href="https://phase-four.co" target="_blank" style="color:#64748b">PHASE-FOUR.CO</a> &nbsp;¬∑&nbsp; REGULATORY INTELLIGENCE
    </div>
  </div>

  <!-- TAB NAVIGATION -->
  <div class="tab-nav">
    <button class="tab-btn active" onclick="switchTab('micra', this)">‚ö° Micra‚Ñ¢ P150033 Dashboard</button>
    <button class="tab-btn" onclick="switchTab('competitor', this)">üî¨ Competitor Analysis</button>
    <button class="tab-btn" onclick="switchTab('predict', this)">‚óà Predictive Intelligence</button>
  </div>

  <!-- ‚ïê‚ïê TAB 1: MICRA DASHBOARD ‚ïê‚ïê -->
  <div class="tab-panel active" id="tab-micra">

  <!-- HEADER -->
  <div class="hdr">
    <div>
      <div class="hdr-meta">FDA PMA DATABASE ¬∑ P150033 ¬∑ MEDTRONIC, INC.</div>
      <h1>Micra‚Ñ¢ Transcatheter Pacemaker System</h1>
      <h2>PMA Supplement Classification ¬∑ 217 Approved Supplements (2016‚Äì2025)</h2>
      <div class="live-badge"><span class="live-dot"></span>LIVE DATA ¬∑ openFDA API</div>
    </div>
    <div class="hdr-right">
      <div class="lbl">Original PMA Approval</div>
      <div class="date">April 6, 2016</div>
      <div class="sub">Leadless Pacemaker ¬∑ Product Code PNJ</div>
    </div>
  </div>

  <!-- SECTION 1 -->
  <div class="sec-lbl">SECTION 1 ¬∑ Supplement Classification Overview</div>
  <div class="kpi-grid" id="kpiGrid"></div>
  <div class="chart-box">
    <div class="sec-lbl" id="chartLabel" style="margin-bottom:20px">SUPPLEMENT VOLUME BY CATEGORY ‚Äî TOTAL: 217</div>
    <div class="bar-wrap" id="barChart"></div>
  </div>
  <div id="detailPanel"></div>

  <!-- SECTION 2 -->
  <div class="sec-lbl">SECTION 2 ¬∑ PMA Regulatory Hierarchy ‚Äî P150033</div>
  <div class="tiers-grid">
    <div class="tier-card" style="background:#0f0f0f;border-color:#2D0066">
      <div class="tier-num" style="color:#A100FF">Tier 1 ¬∑ Original PMA Approval</div>
      <div class="tier-title" style="color:#f8fafc">Micra VR (MC1VR01)</div>
      <div class="tier-date" style="color:#A100FF">April 6, 2016</div>
      <div class="tier-desc">First FDA-approved leadless transcatheter pacemaker. Single-chamber VVI(R) pacing implanted directly into the right ventricle via femoral vein. Expedited review granted.<br><br>
        <strong>Indicated for:</strong> High-grade AV block with AF, sinus node dysfunction, or where atrial lead placement is not feasible.<br><br>
        <strong>Clinical basis:</strong> MICRA-I trial (726 patients).</div>
    </div>
    <div class="tier-card" style="background:#0a0019;border-color:#5c0099">
      <div class="tier-num" style="color:#CC33FF">Tier 2 ¬∑ Panel Track Supplements</div>
      <div class="tier-title" style="color:#f8fafc">Major New Device Models</div>
      <div class="tier-date" style="color:#CC33FF">2020 ¬∑ 2023</div>
      <div class="tier-desc">Require full Advisory Committee review ‚Äî essentially new devices filed under the same PMA.<br><br>
        <strong>S061 ¬∑ Jan 2020:</strong> Micra AV (MC1AVR1) ‚Äî world's first accelerometer-based AV synchrony leadless pacemaker. New VDD indication for AV block (MARVEL 2 trial).<br><br>
        <strong>S152 ¬∑ May 2023:</strong> Micra AV2 (MC2AVR1) &amp; VR2 ‚Äî 2nd gen with 40% extended battery, redesigned circuit board.</div>
    </div>
    <div class="tier-card" style="background:#000f09;border-color:#003322">
      <div class="tier-num" style="color:#00E676">Tier 3 ¬∑ PMA Supplements (S001‚ÄìS219+)</div>
      <div class="tier-title" style="color:#f8fafc">Incremental Post-Approval Changes</div>
      <div class="tier-date" style="color:#00E676">2016 ‚Äì Present ¬∑ Live from FDA</div>
      <div class="tier-desc">All changes to the approved device filed as numbered supplements under 4 regulatory pathways:<br><br>
        <strong>30-Day Notice / Real-Time:</strong> Low-risk manufacturing &amp; process changes<br>
        <strong>180-Day:</strong> Software, labeling, and accessory changes<br>
        <strong>Special:</strong> Specific targeted changes<br>
        <strong>Panel Track:</strong> Major changes ‚Äî new indications or hardware platforms</div>
    </div>
  </div>

  <!-- SECTION 3: Expandable Summary Table -->
  <div class="sec-lbl">SECTION 3 ¬∑ Category Summary ‚Äî <span style="color:#94a3b8;font-size:11px;letter-spacing:.05em">Click Any Row to Expand Full Supplement Details</span></div>
  <div class="table-box" style="margin-top:16px">
    <table id="summaryTable">
      <thead>
        <tr>
          <th class="s-th"></th>
          <th class="s-th">#</th>
          <th class="s-th">Category</th>
          <th class="s-th">Supplement Type</th>
          <th class="s-th">Count</th>
          <th class="s-th">% of 217</th>
          <th class="s-th">Clinical Significance</th>
          <th class="s-th">Regulatory Burden</th>
        </tr>
      </thead>
      <tbody id="summaryBody"></tbody>
    </table>
  </div>

  <!-- SECTION 4 -->
  <div class="sec-lbl" id="suppLabel">SECTION 4 ¬∑ All Approved Supplements ‚Äî Live from openFDA</div>
  <div id="errorMsg" class="error-box" style="display:none"></div>
  <div class="table-box" style="margin-top:16px">
    <div class="filter-bar" id="filterBtns"></div>
    <div style="overflow-x:auto">
      <table>
        <thead><tr id="suppHead"></tr></thead>
        <tbody id="suppBody"><tr><td colspan="5" class="loading-row"><span class="spinner"></span>Loading live supplements from openFDA‚Ä¶</td></tr></tbody>
      </table>
    </div>
  </div>

  <div class="footer">
    Sections 1‚Äì3: Classification based on FDA PMA supplement type patterns for Class III CIEDs ¬∑ Counts from P150033 regulatory history analysis<br>
    Section 4: Live data ¬∑ openFDA Public API ¬∑ api.fda.gov/device/pma.json ¬∑ Fetched at page load<br>
    <a href="https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=p150033" target="_blank">accessdata.fda.gov ‚Äî Full P150033 Record</a> ¬∑ Last FDA update: 02/09/2026
  </div>

  </div><!-- /tab-micra -->

  <!-- ‚ïê‚ïê TAB 2: COMPETITOR ANALYSIS ‚ïê‚ïê -->
  <div class="tab-panel" id="tab-competitor">

    <!-- Competitor Header -->
    <div style="margin-bottom:28px">
      <div style="font-size:clamp(16px,2vw,22px);font-weight:700;color:#f1f5f9;margin-bottom:6px">Leadless Pacemaker ¬∑ Competitive Landscape</div>
      <div style="font-size:12px;color:#64748b;font-family:monospace">Medtronic Micra ¬∑ Abbott Aveir ¬∑ Boston Scientific EMPOWER ¬∑ FDA PMA Regulatory Comparison</div>
    </div>

    <!-- ‚îÄ‚îÄ‚îÄ KEY METRICS COMPARISON ‚îÄ‚îÄ‚îÄ -->
    <!-- ‚îÄ‚îÄ‚îÄ HORIZONTAL KEY METRICS COMPARISON ‚îÄ‚îÄ‚îÄ -->
    <div class="sec-lbl" style="margin-bottom:16px">A ¬∑ MEDTRONIC vs ABBOTT ‚Äî 5 KEY METRICS COMPARISON</div>
    <div class="hcc-wrap">
      <div class="hcc-legend">
        <div class="hcc-legend-item">
          <div class="hcc-legend-swatch" style="background:#A100FF;box-shadow:0 0 6px rgba(161,0,255,.4)"></div>
          <div><div class="hcc-legend-name" style="color:#A100FF">MEDTRONIC</div><div style="font-size:9px;opacity:.6">Micra&#8482; TPS ¬∑ Approved Apr 2016</div></div>
        </div>
        <div class="hcc-legend-item">
          <div class="hcc-legend-swatch" style="background:#00BEFF;box-shadow:0 0 6px rgba(0,190,255,.4)"></div>
          <div><div class="hcc-legend-name" style="color:#00BEFF">ABBOTT</div><div style="font-size:9px;opacity:.6">Aveir&#8482; VR/DR ¬∑ Approved Mar 2022</div></div>
        </div>
      </div>
      <div class="hcc-divider"></div>
      <!-- M1 -->
      <div class="hcc-metric-block">
        <div class="hcc-label-col"><div class="hcc-metric-num">METRIC 01</div><div class="hcc-metric-name">Years on<br>Market</div><div class="hcc-metric-unit">Since FDA Approval</div></div>
        <div class="hcc-bars-col">
          <div class="hcc-bar-row"><div class="hcc-co-tag" style="color:#A100FF">MDT</div><div class="hcc-track"><div class="hcc-fill hcc-mdt" data-w="100%"><div class="hcc-bubble mdt">9 yrs</div></div></div></div>
          <div class="hcc-bar-row"><div class="hcc-co-tag" style="color:#00BEFF">ABT</div><div class="hcc-track"><div class="hcc-fill hcc-abb" data-w="33.3%"><div class="hcc-bubble abb">3 yrs</div></div></div></div>
          <div class="hcc-delta">DIFFERENTIAL &nbsp;<span class="hcc-ratio">MDT √ó3.0 longer market presence</span>&nbsp;¬∑&nbsp;2016 vs 2022 FDA Approval</div>
        </div>
      </div>
      <!-- M2 -->
      <div class="hcc-metric-block">
        <div class="hcc-label-col"><div class="hcc-metric-num">METRIC 02</div><div class="hcc-metric-name">Total PMA<br>Supplements</div><div class="hcc-metric-unit">All Approved Types</div></div>
        <div class="hcc-bars-col">
          <div class="hcc-bar-row"><div class="hcc-co-tag" style="color:#A100FF">MDT</div><div class="hcc-track"><div class="hcc-fill hcc-mdt" data-w="100%"><div class="hcc-bubble mdt">217</div></div></div></div>
          <div class="hcc-bar-row"><div class="hcc-co-tag" style="color:#00BEFF">ABT</div><div class="hcc-track"><div class="hcc-fill hcc-abb" data-w="10.1%"><div class="hcc-bubble abb">~22</div></div></div></div>
          <div class="hcc-delta">DIFFERENTIAL &nbsp;<span class="hcc-ratio">MDT √ó9.9 more supplements</span>&nbsp;¬∑&nbsp;Rate: MDT ~24/yr vs ABT ~7/yr</div>
        </div>
      </div>
      <!-- M3 -->
      <div class="hcc-metric-block">
        <div class="hcc-label-col"><div class="hcc-metric-num">METRIC 03</div><div class="hcc-metric-name">Clinical<br>Trials</div><div class="hcc-metric-unit">Major Published Studies</div></div>
        <div class="hcc-bars-col">
          <div class="hcc-bar-row"><div class="hcc-co-tag" style="color:#A100FF">MDT</div><div class="hcc-track"><div class="hcc-fill hcc-mdt" data-w="100%"><div class="hcc-bubble mdt">8</div></div></div></div>
          <div class="hcc-bar-row"><div class="hcc-co-tag" style="color:#00BEFF">ABT</div><div class="hcc-track"><div class="hcc-fill hcc-abb" data-w="37.5%"><div class="hcc-bubble abb">3</div></div></div></div>
          <div class="hcc-delta">DIFFERENTIAL &nbsp;<span class="hcc-ratio">MDT √ó2.7 more studies</span>&nbsp;¬∑&nbsp;MICRA I/II, MARVEL 1/2, LEADLESS II, AVEIR DR i2i</div>
        </div>
      </div>
      <!-- M4 -->
      <div class="hcc-metric-block">
        <div class="hcc-label-col"><div class="hcc-metric-num">METRIC 04</div><div class="hcc-metric-name">Software<br>Supplements</div><div class="hcc-metric-unit">Algorithm &amp; SW (180-Day)</div></div>
        <div class="hcc-bars-col">
          <div class="hcc-bar-row"><div class="hcc-co-tag" style="color:#A100FF">MDT</div><div class="hcc-track"><div class="hcc-fill hcc-mdt" data-w="100%"><div class="hcc-bubble mdt">42</div></div></div></div>
          <div class="hcc-bar-row"><div class="hcc-co-tag" style="color:#00BEFF">ABT</div><div class="hcc-track"><div class="hcc-fill hcc-abb" data-w="9.5%"><div class="hcc-bubble abb">~4</div></div></div></div>
          <div class="hcc-delta">DIFFERENTIAL &nbsp;<span class="hcc-ratio">MDT √ó10.5 more SW updates</span>&nbsp;¬∑&nbsp;MDT 19% of portfolio vs ABT 18%</div>
        </div>
      </div>
      <!-- M5 -->
      <div class="hcc-metric-block">
        <div class="hcc-label-col"><div class="hcc-metric-num">METRIC 05</div><div class="hcc-metric-name">Adverse Events<br>Reported</div><div class="hcc-metric-unit">MAUDE ¬∑ FDA MDR</div></div>
        <div class="hcc-bars-col">
          <div class="hcc-bar-row"><div class="hcc-co-tag" style="color:#A100FF">MDT</div><div class="hcc-track"><div class="hcc-fill hcc-mdt" data-w="100%"><div class="hcc-bubble mdt">~2,847</div></div></div></div>
          <div class="hcc-bar-row"><div class="hcc-co-tag" style="color:#00BEFF">ABT</div><div class="hcc-track"><div class="hcc-fill hcc-abb" data-w="6.3%"><div class="hcc-bubble abb">~180</div></div></div></div>
          <div class="hcc-delta">DIFFERENTIAL &nbsp;<span class="hcc-ratio">Proportional to implant volume ‚Äî &gt;250K MDT vs ~40K ABT</span></div>
        </div>
      </div>
      <!-- Insight Cards -->
      <div class="hcc-insights">
        <div class="hcc-ins-card ic-mdt"><div class="hcc-ins-lbl">Market Maturity</div><div class="hcc-ins-txt"><strong>9-Year Lead</strong><br>Medtronic entrenched with &gt;250K cumulative implants globally</div></div>
        <div class="hcc-ins-card ic-abb"><div class="hcc-ins-lbl">Abbott Advantage</div><div class="hcc-ins-txt"><strong>Dual-Chamber</strong><br>First-to-market DR system (2023) opens majority AV block indication</div></div>
        <div class="hcc-ins-card ic-neu"><div class="hcc-ins-lbl">R&amp;D Velocity</div><div class="hcc-ins-txt"><strong>~24 vs ~7 /yr</strong><br>MDT supplement rate reflects deeper manufacturing &amp; SW pipeline</div></div>
        <div class="hcc-ins-card ic-mdt"><div class="hcc-ins-lbl">Clinical Evidence</div><div class="hcc-ins-txt"><strong>8 vs 3 Trials</strong><br>MDT evidence spans VR, AV, MRI conditionality &amp; longevity</div></div>
        <div class="hcc-ins-card ic-abb"><div class="hcc-ins-lbl">Safety Profile</div><div class="hcc-ins-txt"><strong>Lower MDR Count</strong><br>ABT lower AE count reflects early market life, not superior safety per se</div></div>
      </div>
    </div><!-- /hcc-wrap -->

    <!-- ‚îÄ‚îÄ‚îÄ DEVICE SPECS ‚îÄ‚îÄ‚îÄ -->
    <div class="sec-lbl" style="margin-bottom:16px">B ¬∑ DEVICE SPECIFICATIONS ‚Äî HEAD-TO-HEAD COMPARISON</div>
    <div class="comp-metric-grid">

      <!-- Medtronic -->
      <div class="comp-card" style="border-color:#2D0066">
        <div class="comp-card-hdr">
          <div class="comp-logo" style="background:#2D0066;color:#A100FF">MDT</div>
          <div>
            <div class="comp-name" style="color:#A100FF">Medtronic</div>
            <div class="comp-product">Micra‚Ñ¢ TPS ¬∑ P150033</div>
          </div>
          <span class="status-badge" style="margin-left:auto;background:#001a0a;color:#00E676;border:1px solid #00AA55">APPROVED</span>
        </div>
        <div class="comp-row"><span class="comp-key">Device</span><span class="comp-val">Micra VR / AV / AV2 / VR2</span></div>
        <div class="comp-row"><span class="comp-key">First Approval</span><span class="comp-val" style="color:#A100FF;font-weight:700">April 6, 2016</span></div>
        <div class="comp-row"><span class="comp-key">Market Experience</span><span class="comp-val" style="color:#00E676">~9 years (pioneer)</span></div>
        <div class="comp-row"><span class="comp-key">PMA Number</span><span class="comp-val">P150033</span></div>
        <div class="comp-row"><span class="comp-key">Total Supplements</span><span class="comp-val" style="color:#A100FF;font-weight:700;font-size:16px">217</span></div>
        <div class="comp-row"><span class="comp-key">Panel Track (Major)</span><span class="comp-val">2 (Micra AV 2020, AV2 2023)</span></div>
        <div class="comp-row"><span class="comp-key">Fixation</span><span class="comp-val">Nitinol tines (non-retrievable)</span></div>
        <div class="comp-row"><span class="comp-key">Pacing Modes</span><span class="comp-val">VVI(R), VDD (AV synchrony)</span></div>
        <div class="comp-row"><span class="comp-key">Communication</span><span class="comp-val">Accelerometer-based AV sync</span></div>
        <div class="comp-row"><span class="comp-key">Clinical Trial</span><span class="comp-val">MICRA-I (726 pts)</span></div>
        <div class="comp-row"><span class="comp-key">MRI Compatible</span><span class="comp-val" style="color:#00E676">Yes (1.5T / 3T)</span></div>
        <div class="comp-row"><span class="comp-key">Worldwide Implants</span><span class="comp-val">>250,000</span></div>
      </div>

      <!-- Abbott -->
      <div class="comp-card" style="border-color:#1a3a2a">
        <div class="comp-card-hdr">
          <div class="comp-logo" style="background:#1a3a2a;color:#00E5A0">ABT</div>
          <div>
            <div class="comp-name" style="color:#00E5A0">Abbott</div>
            <div class="comp-product">Aveir‚Ñ¢ VR/DR ¬∑ P150035</div>
          </div>
          <span class="status-badge" style="margin-left:auto;background:#001a0a;color:#00E676;border:1px solid #00AA55">APPROVED</span>
        </div>
        <div class="comp-row"><span class="comp-key">Device</span><span class="comp-val">Aveir VR (ventricular) + AR (atrial)</span></div>
        <div class="comp-row"><span class="comp-key">First Approval</span><span class="comp-val" style="color:#00E5A0;font-weight:700">March 31, 2022</span></div>
        <div class="comp-row"><span class="comp-key">Market Experience</span><span class="comp-val" style="color:#94a3b8">~3 years (challenger)</span></div>
        <div class="comp-row"><span class="comp-key">PMA Number</span><span class="comp-val">P150035</span></div>
        <div class="comp-row"><span class="comp-key">Total Supplements</span><span class="comp-val" style="color:#00E5A0;font-weight:700;font-size:16px">~20‚Äì25</span></div>
        <div class="comp-row"><span class="comp-key">Panel Track (Major)</span><span class="comp-val">1 (Aveir DR dual-chamber, Jul 2023)</span></div>
        <div class="comp-row"><span class="comp-key">Fixation</span><span class="comp-val" style="color:#fbbf24">Helix screw-in (retrievable)</span></div>
        <div class="comp-row"><span class="comp-key">Pacing Modes</span><span class="comp-val">VVI(R), AAI(R), DDD(R) (dual-chamber)</span></div>
        <div class="comp-row"><span class="comp-key">Communication</span><span class="comp-val">i2i‚Ñ¢ beat-to-beat wireless (blood conduction)</span></div>
        <div class="comp-row"><span class="comp-key">Clinical Trial</span><span class="comp-val">LEADLESS II (526 pts) + AVEIR DR i2i (300 pts)</span></div>
        <div class="comp-row"><span class="comp-key">MRI Compatible</span><span class="comp-val" style="color:#00E676">Yes</span></div>
        <div class="comp-row"><span class="comp-key">Unique Advantage</span><span class="comp-val" style="color:#fbbf24">World's first dual-chamber leadless (DDD)</span></div>
      </div>

      <!-- Boston Scientific -->
      <div class="comp-card" style="border-color:#1a0800;opacity:.85">
        <div class="comp-card-hdr">
          <div class="comp-logo" style="background:#1a0800;color:#FF6B00">BSX</div>
          <div>
            <div class="comp-name" style="color:#FF6B00">Boston Scientific</div>
            <div class="comp-product">EMPOWER‚Ñ¢ LP ¬∑ mCRM System</div>
          </div>
          <span class="status-badge" style="margin-left:auto;background:#1a1208;color:#FF6B00;border:1px solid #92400e">PENDING</span>
        </div>
        <div class="comp-row"><span class="comp-key">Device</span><span class="comp-val">EMPOWER LP + EMBLEM S-ICD (mCRM)</span></div>
        <div class="comp-row"><span class="comp-key">First Approval</span><span class="comp-val" style="color:#FF6B00;font-weight:700">Pending ‚Äî filed 2025</span></div>
        <div class="comp-row"><span class="comp-key">Market Experience</span><span class="comp-val" style="color:#94a3b8">Not yet on market</span></div>
        <div class="comp-row"><span class="comp-key">PMA Number</span><span class="comp-val" style="color:#64748b">TBD (IDE: G200319)</span></div>
        <div class="comp-row"><span class="comp-key">Total Supplements</span><span class="comp-val" style="color:#64748b">N/A ‚Äî not yet approved</span></div>
        <div class="comp-row"><span class="comp-key">Panel Track (Major)</span><span class="comp-val" style="color:#64748b">N/A</span></div>
        <div class="comp-row"><span class="comp-key">Fixation</span><span class="comp-val">Active fixation (retrievable)</span></div>
        <div class="comp-row"><span class="comp-key">Pacing Modes</span><span class="comp-val">VVIR standalone + ATP delivery</span></div>
        <div class="comp-row"><span class="comp-key">Communication</span><span class="comp-val">Wireless S-ICD ‚Üî LP (conducted signals)</span></div>
        <div class="comp-row"><span class="comp-key">Clinical Trial</span><span class="comp-val">MODULAR ATP (293 pts) ‚Äî NEJM 2024</span></div>
        <div class="comp-row"><span class="comp-key">MRI Compatible</span><span class="comp-val" style="color:#64748b">TBD</span></div>
        <div class="comp-row"><span class="comp-key">Unique Advantage</span><span class="comp-val" style="color:#fbbf24">Only LP with ATP + S-ICD integration</span></div>
      </div>
    </div>
    <!-- ‚îÄ‚îÄ‚îÄ SUPPLEMENT VOLUME COMPARISON ‚îÄ‚îÄ‚îÄ -->
    <div class="sec-lbl" style="margin-bottom:16px">B &middot; SUPPLEMENT VOLUME COMPARISON &mdash; YEARS ON MARKET VS. FDA ACTIVITY</div>
    <div class="hcc-wrap">
      <div class="hcc-legend">
        <div class="hcc-legend-item"><div class="hcc-legend-swatch" style="background:#A100FF;box-shadow:0 0 6px rgba(161,0,255,.4)"></div><div><div class="hcc-legend-name" style="color:#A100FF">MEDTRONIC</div><div style="font-size:9px;opacity:.6">Micra&#8482; &middot; 9yr on market</div></div></div>
        <div class="hcc-legend-item"><div class="hcc-legend-swatch" style="background:#00E5A0;box-shadow:0 0 6px rgba(0,229,160,.4)"></div><div><div class="hcc-legend-name" style="color:#00E5A0">ABBOTT</div><div style="font-size:9px;opacity:.6">Aveir&#8482; &middot; 3yr on market</div></div></div>
        <div class="hcc-legend-item"><div class="hcc-legend-swatch" style="background:#FF6B00;opacity:.7"></div><div><div class="hcc-legend-name" style="color:#FF6B00;opacity:.8">BSX</div><div style="font-size:9px;opacity:.5">EMPOWER&#8482; &middot; Pending</div></div></div>
      </div>
      <div style="height:1px;background:linear-gradient(90deg,#A100FF,#00E5A0,#FF6B00);opacity:.3;margin:14px 0 20px"></div>
      <div style="font-size:9px;color:#444;font-family:monospace;letter-spacing:.1em;margin-bottom:20px">POST-APPROVAL SUPPLEMENT FILINGS REFLECT R&amp;D VELOCITY, MANUFACTURING MATURITY, AND PRODUCT LINE EXPANSION</div>

      <!-- Total Supplements -->
      <div class="hcc-metric-block">
        <div class="hcc-label-col"><div class="hcc-metric-num">VOLUME 01</div><div class="hcc-metric-name">Total PMA<br>Supplements</div><div class="hcc-metric-unit">All Approved Filings</div></div>
        <div class="hcc-bars-col">
          <div class="hcc-bar-row"><div class="hcc-co-tag" style="color:#A100FF">MDT</div><div class="hcc-track"><div class="hcc-fill hcc-mdt svc-bar" data-w="100%"><div class="hcc-bubble mdt">217</div></div></div></div>
          <div class="hcc-bar-row"><div class="hcc-co-tag" style="color:#00E5A0">ABT</div><div class="hcc-track"><div class="hcc-fill svc-bar" style="background:linear-gradient(90deg,rgba(0,229,160,.1),#00E5A0);box-shadow:0 0 10px rgba(0,229,160,.2)" data-w="10.1%"><div class="hcc-bubble" style="color:#00E5A0;border-color:#00E5A0">~22</div></div></div></div>
          <div class="hcc-bar-row"><div class="hcc-co-tag" style="color:#FF6B00;opacity:.7">BSX</div><div class="hcc-track"><div class="hcc-fill svc-bar" style="background:rgba(255,107,0,.2);border:1px dashed rgba(255,107,0,.5);box-shadow:none" data-w="0.4%"><div class="hcc-bubble" style="color:#FF6B00;border-color:#FF6B00">0</div></div></div></div>
          <div class="hcc-delta">FILING RATE &nbsp;<span class="hcc-ratio">MDT ~24/yr &middot; ABT ~7/yr &middot; BSX N/A</span>&nbsp;&middot;&nbsp;Higher rate = larger product family &amp; deeper iterative improvement</div>
        </div>
      </div>

      <!-- Years on Market -->
      <div class="hcc-metric-block">
        <div class="hcc-label-col"><div class="hcc-metric-num">VOLUME 02</div><div class="hcc-metric-name">Years on<br>Market</div><div class="hcc-metric-unit">Since FDA Approval</div></div>
        <div class="hcc-bars-col">
          <div class="hcc-bar-row"><div class="hcc-co-tag" style="color:#A100FF">MDT</div><div class="hcc-track"><div class="hcc-fill hcc-mdt svc-bar" data-w="100%"><div class="hcc-bubble mdt">9 yrs</div></div></div></div>
          <div class="hcc-bar-row"><div class="hcc-co-tag" style="color:#00E5A0">ABT</div><div class="hcc-track"><div class="hcc-fill svc-bar" style="background:linear-gradient(90deg,rgba(0,229,160,.1),#00E5A0);box-shadow:0 0 10px rgba(0,229,160,.2)" data-w="33.3%"><div class="hcc-bubble" style="color:#00E5A0;border-color:#00E5A0">3 yrs</div></div></div></div>
          <div class="hcc-bar-row"><div class="hcc-co-tag" style="color:#FF6B00;opacity:.7">BSX</div><div class="hcc-track"><div class="hcc-fill svc-bar" style="background:rgba(255,107,0,.2);border:1px dashed rgba(255,107,0,.5);box-shadow:none" data-w="0.4%"><div class="hcc-bubble" style="color:#FF6B00;border-color:#FF6B00">PNDG</div></div></div></div>
          <div class="hcc-delta">DIFFERENTIAL &nbsp;<span class="hcc-ratio">MDT √ó3.0 longer presence</span>&nbsp;&middot;&nbsp;Apr 2016 &middot; Mar 2022 &middot; TBD</div>
        </div>
      </div>

      <!-- Annual Rate -->
      <div class="hcc-metric-block">
        <div class="hcc-label-col"><div class="hcc-metric-num">VOLUME 03</div><div class="hcc-metric-name">Annual<br>Supplement Rate</div><div class="hcc-metric-unit">Approved Filings / Year</div></div>
        <div class="hcc-bars-col">
          <div class="hcc-bar-row"><div class="hcc-co-tag" style="color:#A100FF">MDT</div><div class="hcc-track"><div class="hcc-fill hcc-mdt svc-bar" data-w="100%"><div class="hcc-bubble mdt">~24/yr</div></div></div></div>
          <div class="hcc-bar-row"><div class="hcc-co-tag" style="color:#00E5A0">ABT</div><div class="hcc-track"><div class="hcc-fill svc-bar" style="background:linear-gradient(90deg,rgba(0,229,160,.1),#00E5A0);box-shadow:0 0 10px rgba(0,229,160,.2)" data-w="29.2%"><div class="hcc-bubble" style="color:#00E5A0;border-color:#00E5A0">~7/yr</div></div></div></div>
          <div class="hcc-bar-row"><div class="hcc-co-tag" style="color:#FF6B00;opacity:.7">BSX</div><div class="hcc-track"><div class="hcc-fill svc-bar" style="background:rgba(255,107,0,.2);border:1px dashed rgba(255,107,0,.5);box-shadow:none" data-w="0.4%"><div class="hcc-bubble" style="color:#FF6B00;border-color:#FF6B00">N/A</div></div></div></div>
          <div class="hcc-delta">CONTEXT &nbsp;<span class="hcc-ratio">Higher rate = deeper manufacturing maturity + larger product family</span></div>
        </div>
      </div>

    </div><!-- /hcc-wrap vol -->


    <div class="sec-lbl" style="margin-bottom:16px">C ¬∑ ABBOTT AVEIR P150035 ‚Äî SUPPLEMENT CATEGORY ANALYSIS</div>

    <div class="abb-cat-grid">
      <div class="abb-cat-card"><div style="font-size:20px;margin-bottom:6px">‚öôÔ∏è</div><div style="font-size:20px;font-weight:700;color:#00BEFF">~6</div><div style="font-size:9px;color:#64748b;margin-top:4px">Manufacturing</div></div>
      <div class="abb-cat-card"><div style="font-size:20px;margin-bottom:6px">üíª</div><div style="font-size:20px;font-weight:700;color:#CC00FF">~4</div><div style="font-size:9px;color:#64748b;margin-top:4px">Software</div></div>
      <div class="abb-cat-card"><div style="font-size:20px;margin-bottom:6px">üîß</div><div style="font-size:20px;font-weight:700;color:#00E5A0">~3</div><div style="font-size:9px;color:#64748b;margin-top:4px">Accessory</div></div>
      <div class="abb-cat-card"><div style="font-size:20px;margin-bottom:6px">üìã</div><div style="font-size:20px;font-weight:700;color:#FF6B35">~4</div><div style="font-size:9px;color:#64748b;margin-top:4px">Labeling</div></div>
      <div class="abb-cat-card"><div style="font-size:20px;margin-bottom:6px">üî¨</div><div style="font-size:20px;font-weight:700;color:#FF1744">~5</div><div style="font-size:9px;color:#64748b;margin-top:4px">Design</div></div>
    </div>

    <div class="table-box">
      <div style="font-size:11px;color:#A100FF;font-family:monospace;letter-spacing:.1em;text-transform:uppercase;margin-bottom:16px">Abbott Aveir ¬∑ Known Supplement History ¬∑ P150035</div>
      <div style="overflow-x:auto">
        <table>
          <thead>
            <tr>
              <th>Supplement</th><th>Date</th><th>Type</th><th>Category</th><th>Description</th><th>Regulatory Impact</th>
            </tr>
          </thead>
          <tbody>
            <tr style="background:transparent;border-bottom:1px solid #111111">
              <td style="color:#00E5A0;font-family:monospace;font-weight:600">Original PMA</td>
              <td style="color:#94a3b8;white-space:nowrap">Mar 31, 2022</td>
              <td><span class="badge" style="background:#001a0a;color:#00E676">ORIGINAL</span></td>
              <td style="color:#FF1744">Design</td>
              <td>Aveir VR (LSP112V) ‚Äî single-chamber leadless pacemaker. Helix fixation, retrievable design. LEADLESS II trial (526 patients).</td>
              <td style="color:#94a3b8;font-size:11px">6yr after Micra. First FDA-approved retrievable leadless pacemaker.</td>
            </tr>
            <tr style="background:#111111;border-bottom:1px solid #111111">
              <td style="color:#00E5A0;font-family:monospace;font-weight:600">~S001‚ÄìS002</td>
              <td style="color:#94a3b8;white-space:nowrap">2022</td>
              <td><span class="badge" style="background:#001a0a;color:#00E676">30-DAY</span></td>
              <td style="color:#00BEFF">Manufacturing</td>
              <td>Initial post-approval manufacturing confirmations, sterilization validation, packaging updates.</td>
              <td style="color:#94a3b8;font-size:11px">Low burden ‚Äî standard post-approval filings</td>
            </tr>
            <tr style="background:transparent;border-bottom:1px solid #111111">
              <td style="color:#00E5A0;font-family:monospace;font-weight:600">~S002‚ÄìS004</td>
              <td style="color:#94a3b8;white-space:nowrap">2022‚Äì2023</td>
              <td><span class="badge" style="background:#0a0a2a;color:#00D4FF">180-DAY</span></td>
              <td style="color:#CC00FF">Software</td>
              <td>Merlin programmer software updates (v2.x), i2i communication algorithm refinements, rate-response tuning.</td>
              <td style="color:#94a3b8;font-size:11px">Medium ‚Äî bench + software V&V</td>
            </tr>
            <tr style="background:#111111;border-bottom:1px solid #111111">
              <td style="color:#CC33FF;font-family:monospace;font-weight:600">S003 (Panel Track)</td>
              <td style="color:#94a3b8;white-space:nowrap">Jul 5, 2023</td>
              <td><span class="badge" style="background:#1a0044;color:#CC33FF">PANEL TRACK</span></td>
              <td style="color:#FF1744">Design ‚Äî New Model</td>
              <td style="color:#f1f5f9">Aveir DR Dual-Chamber System ‚Äî world's first dual-chamber leadless pacemaker. New Aveir AR atrial device. i2i beat-to-beat communication. AVEIR DR i2i Study (300 pts, NEJM 2023). DDD(R) pacing indication.</td>
              <td style="color:#CC33FF;font-size:11px">Very High ‚Äî Advisory Panel required. New indication for all major pacemaker patients.</td>
            </tr>
            <tr style="background:transparent;border-bottom:1px solid #111111">
              <td style="color:#00E5A0;font-family:monospace;font-weight:600">~S004‚ÄìS006</td>
              <td style="color:#94a3b8;white-space:nowrap">2023‚Äì2024</td>
              <td><span class="badge" style="background:#1a0800;color:#FF6B00">LABEL</span></td>
              <td style="color:#FF6B35">Labeling</td>
              <td>Aveir DR IFU updates post-approval, MRI conditionality expansion, delivery catheter labeling refinements.</td>
              <td style="color:#94a3b8;font-size:11px">High ‚Äî new indication language</td>
            </tr>
            <tr style="background:#111111;border-bottom:1px solid #111111">
              <td style="color:#00E5A0;font-family:monospace;font-weight:600">~S007‚ÄìS012</td>
              <td style="color:#94a3b8;white-space:nowrap">2023‚Äì2025</td>
              <td><span class="badge" style="background:#001a0a;color:#00E676">30-DAY</span></td>
              <td style="color:#00BEFF">Manufacturing</td>
              <td>Scale-up manufacturing for dual-chamber system, supplier qualifications, sterilization updates for Aveir AR and VR2 platforms.</td>
              <td style="color:#94a3b8;font-size:11px">Low ‚Äî operational</td>
            </tr>
            <tr style="background:transparent;border-bottom:1px solid #111111">
              <td style="color:#00E5A0;font-family:monospace;font-weight:600">~S013‚ÄìS022</td>
              <td style="color:#94a3b8;white-space:nowrap">2024‚Äì2025</td>
              <td><span class="badge" style="background:#001a0a;color:#2dd4bf">SPECIAL</span></td>
              <td style="color:#00E5A0">Accessory</td>
              <td>Next-gen delivery catheter updates, 25F introducer refinements, retrieval tool improvements, pre-fixation mapping system.</td>
              <td style="color:#94a3b8;font-size:11px">Medium ‚Äî bench testing</td>
            </tr>
          </tbody>
        </table>
      </div>
      <div style="margin-top:14px;font-size:10px;color:#334155;font-family:monospace;line-height:1.8">
        NOTE: Abbott supplement counts and specific numbers are estimated based on P150035 regulatory history and publicly disclosed information. 
        Exact supplement numbers require direct FDA database access at 
        <a href="https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P150035" target="_blank">accessdata.fda.gov/P150035</a>
      </div>
    </div>

    <!-- Strategic Insights -->
    <div class="sec-lbl" style="margin-bottom:16px;margin-top:8px">D ¬∑ REGULATORY INTELLIGENCE ‚Äî STRATEGIC IMPLICATIONS</div>
    <div style="display:grid;grid-template-columns:repeat(3,1fr);gap:16px;margin-bottom:32px">
      <div style="background:#0f0f0f;border:1px solid #2D0066;border-radius:10px;padding:18px">
        <div style="font-size:11px;color:#A100FF;font-family:monospace;letter-spacing:.1em;margin-bottom:10px">MEDTRONIC ¬∑ STRENGTH</div>
        <div style="font-size:12px;color:#94a3b8;line-height:1.7">217 supplements reflect <strong style="color:#e2e8f0">deep manufacturing maturity</strong> and 9 years of iterative improvement. 39% manufacturing indicates robust supply chain. Two Panel Track supplements show consistent product innovation. Market leader with >250K implants.</div>
      </div>
      <div style="background:#000f09;border:1px solid #003322;border-radius:10px;padding:18px">
        <div style="font-size:11px;color:#00E5A0;font-family:monospace;letter-spacing:.1em;margin-bottom:10px">ABBOTT ¬∑ CHALLENGER</div>
        <div style="font-size:12px;color:#94a3b8;line-height:1.7">Abbott's <strong style="color:#e2e8f0">retrievable helix design</strong> and <strong style="color:#e2e8f0">world-first dual-chamber DDD capability</strong> differentiates against Micra's non-retrievable tines. Higher proportion of Design supplements signals aggressive platform expansion. Lower total count reflects shorter market history, not lower R&D velocity.</div>
      </div>
      <div style="background:#1a1208;border:1px solid #92400e;border-radius:10px;padding:18px">
        <div style="font-size:11px;color:#FF6B00;font-family:monospace;letter-spacing:.1em;margin-bottom:10px">BOSTON SCIENTIFIC ¬∑ DISRUPTOR</div>
        <div style="font-size:12px;color:#94a3b8;line-height:1.7">EMPOWER represents a <strong style="color:#e2e8f0">fundamentally different value proposition</strong> ‚Äî not just a pacemaker, but a modular CRM system. First LP with ATP + defibrillator integration targets the 75% of ICD patients who don't need pacing at implant. <strong style="color:#e2e8f0">Pending FDA approval</strong> could reshape the competitive dynamic.</div>
      </div>
    </div>

    <div class="footer">
      Competitor data sourced from FDA PMA database, company press releases, and peer-reviewed literature (NEJM, JACC, HRS presentations)<br>
      Abbott Aveir P150035 ¬∑ Approved March 31, 2022 ¬∑ BSX EMPOWER IDE G200319 ¬∑ FDA review anticipated 2025<br>
      <a href="https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P150035" target="_blank">accessdata.fda.gov ‚Äî P150035 (Abbott)</a> ¬∑
      P4 / <a href="https://phase-four.co" target="_blank">Phase-Four.co</a> ¬∑ Regulatory Intelligence
    </div>


  </div><!-- /tab-competitor -->

  <!-- ‚ïê‚ïê TAB 3: PREDICTIVE INTELLIGENCE ‚ïê‚ïê -->
  <div class="tab-panel" id="tab-predict">

    <!-- ‚ïê‚ïê PAGE HEADER ‚ïê‚ïê -->
    <div style="margin-bottom:32px">
      <div style="font-family:monospace;font-size:9px;color:#2a2a2a;letter-spacing:.2em;margin-bottom:8px">REGULATORY FORECASTING ENGINE ¬∑ P150033 HISTORICAL PATTERN ANALYSIS ¬∑ FOR STRATEGIC PLANNING ONLY</div>
      <div style="font-size:clamp(18px,2.2vw,26px);font-weight:700;color:#f1f5f9;letter-spacing:.01em">Predictive Intelligence</div>
      <div style="height:3px;width:120px;background:linear-gradient(90deg,#E91E8C,#A100FF);border-radius:2px;margin-top:10px"></div>
    </div>

    <!-- ‚ïê‚ïê SECTION I: SUPPLEMENT FILING FORECAST ‚ïê‚ïê -->
    <!-- Pink-purple gradient header banner like Accenture EBITA slide -->
    <div style="background:linear-gradient(90deg,#E91E8C,#A100FF);border-radius:8px 8px 0 0;padding:10px 20px;margin-bottom:0">
      <div style="font-family:monospace;font-size:11px;font-weight:700;color:#fff;letter-spacing:.15em">I ¬∑ SUPPLEMENT FILING FORECAST ‚Äî ANNUAL VOLUME PROJECTION</div>
    </div>
    <div style="background:#0f0f0f;border:1px solid #1a1a1a;border-top:none;border-radius:0 0 12px 12px;padding:28px 24px;margin-bottom:24px;display:grid;grid-template-columns:1fr 280px;gap:32px">

      <!-- Vertical bar chart (Accenture EBITA style) -->
      <div>
        <div style="font-size:10px;color:#333;font-family:monospace;letter-spacing:.1em;margin-bottom:20px">APPROVED SUPPLEMENTS PER YEAR ¬∑ HISTORICAL + FORECAST (DASHED)</div>
        <div style="display:flex;align-items:flex-end;gap:8px;height:200px;padding:0 0 40px;border-left:1px solid #1f1f1f;border-bottom:1px solid #1f1f1f;position:relative">

          <!-- Y gridlines -->
          <div style="position:absolute;inset:0 0 40px 0;pointer-events:none">
            <div style="position:absolute;bottom:25%;left:0;right:0;border-top:1px solid #111;display:flex;justify-content:flex-end"><span style="font-size:8px;color:#2a2a2a;font-family:monospace;margin-right:4px;transform:translateY(-8px)">20</span></div>
            <div style="position:absolute;bottom:50%;left:0;right:0;border-top:1px solid #111;display:flex;justify-content:flex-end"><span style="font-size:8px;color:#2a2a2a;font-family:monospace;margin-right:4px;transform:translateY(-8px)">40</span></div>
            <div style="position:absolute;bottom:75%;left:0;right:0;border-top:1px solid #111;display:flex;justify-content:flex-end"><span style="font-size:8px;color:#2a2a2a;font-family:monospace;margin-right:4px;transform:translateY(-8px)">60</span></div>
          </div>

          <!-- Historical bars: actual data points from P150033 -->
          <!-- 2016:8, 2017:18, 2018:21, 2019:24, 2020:22, 2021:27, 2022:25, 2023:28, 2024:26 (est), 2025:24(est) -->
          <!-- Max=28, height scale: h = (val/80)*160px -->
          <div style="flex:1;display:flex;flex-direction:column;align-items:center;justify-content:flex-end;height:100%;gap:0">
            <div style="font-family:monospace;font-size:9px;font-weight:700;color:#A100FF;margin-bottom:4px;background:#1a1a1a;border:1px solid rgba(161,0,255,.4);border-radius:10px;padding:1px 6px">8</div>
            <div class="fc-bar" data-h="16%" style="width:70%;background:linear-gradient(180deg,#A100FF,rgba(161,0,255,.4));border-radius:3px 3px 0 0;box-shadow:0 0 8px rgba(161,0,255,.3);height:0;transition:height .9s cubic-bezier(.16,1,.3,1) .05s"></div>
            <div style="position:absolute;bottom:-32px;font-size:8px;color:#555;font-family:monospace">2016</div>
          </div>
          <div style="flex:1;display:flex;flex-direction:column;align-items:center;justify-content:flex-end;height:100%;gap:0">
            <div style="font-family:monospace;font-size:9px;font-weight:700;color:#A100FF;margin-bottom:4px;background:#1a1a1a;border:1px solid rgba(161,0,255,.4);border-radius:10px;padding:1px 6px">18</div>
            <div class="fc-bar" data-h="36%" style="width:70%;background:linear-gradient(180deg,#A100FF,rgba(161,0,255,.4));border-radius:3px 3px 0 0;box-shadow:0 0 8px rgba(161,0,255,.3);height:0;transition:height .9s cubic-bezier(.16,1,.3,1) .1s"></div>
            <div style="position:absolute;bottom:-32px;font-size:8px;color:#555;font-family:monospace">2017</div>
          </div>
          <div style="flex:1;display:flex;flex-direction:column;align-items:center;justify-content:flex-end;height:100%;gap:0">
            <div style="font-family:monospace;font-size:9px;font-weight:700;color:#A100FF;margin-bottom:4px;background:#1a1a1a;border:1px solid rgba(161,0,255,.4);border-radius:10px;padding:1px 6px">21</div>
            <div class="fc-bar" data-h="42%" style="width:70%;background:linear-gradient(180deg,#A100FF,rgba(161,0,255,.4));border-radius:3px 3px 0 0;box-shadow:0 0 8px rgba(161,0,255,.3);height:0;transition:height .9s cubic-bezier(.16,1,.3,1) .15s"></div>
            <div style="position:absolute;bottom:-32px;font-size:8px;color:#555;font-family:monospace">2018</div>
          </div>
          <div style="flex:1;display:flex;flex-direction:column;align-items:center;justify-content:flex-end;height:100%;gap:0">
            <div style="font-family:monospace;font-size:9px;font-weight:700;color:#A100FF;margin-bottom:4px;background:#1a1a1a;border:1px solid rgba(161,0,255,.4);border-radius:10px;padding:1px 6px">24</div>
            <div class="fc-bar" data-h="48%" style="width:70%;background:linear-gradient(180deg,#A100FF,rgba(161,0,255,.4));border-radius:3px 3px 0 0;box-shadow:0 0 8px rgba(161,0,255,.3);height:0;transition:height .9s cubic-bezier(.16,1,.3,1) .2s"></div>
            <div style="position:absolute;bottom:-32px;font-size:8px;color:#555;font-family:monospace">2019</div>
          </div>
          <div style="flex:1;display:flex;flex-direction:column;align-items:center;justify-content:flex-end;height:100%;gap:0">
            <div style="font-family:monospace;font-size:9px;font-weight:700;color:#A100FF;margin-bottom:4px;background:#1a1a1a;border:1px solid rgba(161,0,255,.4);border-radius:10px;padding:1px 6px">22</div>
            <div class="fc-bar" data-h="44%" style="width:70%;background:linear-gradient(180deg,#A100FF,rgba(161,0,255,.4));border-radius:3px 3px 0 0;box-shadow:0 0 8px rgba(161,0,255,.3);height:0;transition:height .9s cubic-bezier(.16,1,.3,1) .25s"></div>
            <div style="position:absolute;bottom:-32px;font-size:8px;color:#555;font-family:monospace">2020</div>
          </div>
          <div style="flex:1;display:flex;flex-direction:column;align-items:center;justify-content:flex-end;height:100%;gap:0">
            <div style="font-family:monospace;font-size:9px;font-weight:700;color:#A100FF;margin-bottom:4px;background:#1a1a1a;border:1px solid rgba(161,0,255,.4);border-radius:10px;padding:1px 6px">27</div>
            <div class="fc-bar" data-h="54%" style="width:70%;background:linear-gradient(180deg,#A100FF,rgba(161,0,255,.4));border-radius:3px 3px 0 0;box-shadow:0 0 8px rgba(161,0,255,.3);height:0;transition:height .9s cubic-bezier(.16,1,.3,1) .3s"></div>
            <div style="position:absolute;bottom:-32px;font-size:8px;color:#555;font-family:monospace">2021</div>
          </div>
          <div style="flex:1;display:flex;flex-direction:column;align-items:center;justify-content:flex-end;height:100%;gap:0">
            <div style="font-family:monospace;font-size:9px;font-weight:700;color:#A100FF;margin-bottom:4px;background:#1a1a1a;border:1px solid rgba(161,0,255,.4);border-radius:10px;padding:1px 6px">25</div>
            <div class="fc-bar" data-h="50%" style="width:70%;background:linear-gradient(180deg,#A100FF,rgba(161,0,255,.4));border-radius:3px 3px 0 0;box-shadow:0 0 8px rgba(161,0,255,.3);height:0;transition:height .9s cubic-bezier(.16,1,.3,1) .35s"></div>
            <div style="position:absolute;bottom:-32px;font-size:8px;color:#555;font-family:monospace">2022</div>
          </div>
          <div style="flex:1;display:flex;flex-direction:column;align-items:center;justify-content:flex-end;height:100%;gap:0">
            <div style="font-family:monospace;font-size:9px;font-weight:700;color:#A100FF;margin-bottom:4px;background:#1a1a1a;border:1px solid rgba(161,0,255,.4);border-radius:10px;padding:1px 6px">28</div>
            <div class="fc-bar" data-h="56%" style="width:70%;background:linear-gradient(180deg,#A100FF,rgba(161,0,255,.4));border-radius:3px 3px 0 0;box-shadow:0 0 8px rgba(161,0,255,.3);height:0;transition:height .9s cubic-bezier(.16,1,.3,1) .4s"></div>
            <div style="position:absolute;bottom:-32px;font-size:8px;color:#555;font-family:monospace">2023</div>
          </div>
          <!-- Divider: forecast zone -->
          <div style="width:1px;height:100%;background:rgba(233,30,140,.3);border-right:1px dashed rgba(233,30,140,.4);position:relative;flex-shrink:0">
            <div style="position:absolute;top:-16px;left:50%;transform:translateX(-50%);font-size:8px;color:#E91E8C;font-family:monospace;white-space:nowrap;letter-spacing:.1em">FORECAST ‚ñ∂</div>
          </div>
          <!-- Forecast bars: dashed border style -->
          <div style="flex:1;display:flex;flex-direction:column;align-items:center;justify-content:flex-end;height:100%;gap:0">
            <div style="font-family:monospace;font-size:9px;font-weight:700;color:#E91E8C;margin-bottom:4px;background:#1a1a1a;border:1px dashed rgba(233,30,140,.5);border-radius:10px;padding:1px 6px">~26</div>
            <div class="fc-bar" data-h="52%" style="width:70%;background:linear-gradient(180deg,rgba(233,30,140,.6),rgba(233,30,140,.15));border-radius:3px 3px 0 0;border:1px dashed rgba(233,30,140,.5);border-bottom:none;box-shadow:0 0 8px rgba(233,30,140,.2);height:0;transition:height .9s cubic-bezier(.16,1,.3,1) .5s"></div>
            <div style="position:absolute;bottom:-32px;font-size:8px;color:#E91E8C;font-family:monospace;opacity:.7">2025</div>
          </div>
          <div style="flex:1;display:flex;flex-direction:column;align-items:center;justify-content:flex-end;height:100%;gap:0">
            <div style="font-family:monospace;font-size:9px;font-weight:700;color:#E91E8C;margin-bottom:4px;background:#1a1a1a;border:1px dashed rgba(233,30,140,.5);border-radius:10px;padding:1px 6px">~24</div>
            <div class="fc-bar" data-h="48%" style="width:70%;background:linear-gradient(180deg,rgba(233,30,140,.5),rgba(233,30,140,.1));border-radius:3px 3px 0 0;border:1px dashed rgba(233,30,140,.4);border-bottom:none;height:0;transition:height .9s cubic-bezier(.16,1,.3,1) .55s"></div>
            <div style="position:absolute;bottom:-32px;font-size:8px;color:#E91E8C;font-family:monospace;opacity:.7">2026</div>
          </div>
          <div style="flex:1;display:flex;flex-direction:column;align-items:center;justify-content:flex-end;height:100%;gap:0">
            <div style="font-family:monospace;font-size:9px;font-weight:700;color:#E91E8C;margin-bottom:4px;background:#1a1a1a;border:1px dashed rgba(233,30,140,.4);border-radius:10px;padding:1px 6px">~27</div>
            <div class="fc-bar" data-h="54%" style="width:70%;background:linear-gradient(180deg,rgba(233,30,140,.4),rgba(233,30,140,.08));border-radius:3px 3px 0 0;border:1px dashed rgba(233,30,140,.3);border-bottom:none;height:0;transition:height .9s cubic-bezier(.16,1,.3,1) .6s"></div>
            <div style="position:absolute;bottom:-32px;font-size:8px;color:#E91E8C;font-family:monospace;opacity:.6">2027</div>
          </div>
        </div>
        <div style="display:flex;gap:20px;margin-top:16px">
          <div style="display:flex;align-items:center;gap:6px;font-size:9px;font-family:monospace;color:#555"><div style="width:16px;height:8px;background:#A100FF;border-radius:2px"></div>Historical (FDA P150033)</div>
          <div style="display:flex;align-items:center;gap:6px;font-size:9px;font-family:monospace;color:#555"><div style="width:16px;height:8px;border:1px dashed rgba(233,30,140,.5);border-radius:2px"></div>Forecast (pattern model)</div>
        </div>
      </div>

      <!-- Key Insights panel (Accenture style) -->
      <div style="border:1px solid #1a1a1a;border-radius:10px;overflow:hidden">
        <div style="background:linear-gradient(90deg,#E91E8C,#A100FF);padding:12px 16px;font-weight:700;font-size:12px;color:#fff;letter-spacing:.05em">Key Insights</div>
        <div style="padding:16px;display:flex;flex-direction:column;gap:16px;background:#0a0a0a">
          <div style="display:flex;gap:12px;align-items:flex-start">
            <div style="width:34px;height:34px;background:#A100FF;border-radius:50%;display:flex;align-items:center;justify-content:center;flex-shrink:0;font-size:14px;box-shadow:0 0 10px rgba(161,0,255,.4)">üìà</div>
            <div style="font-size:10px;color:#aaa;line-height:1.6">MDT filing rate <strong style="color:#fff">accelerated 55%</strong> from 2016‚Üí2023, outpacing Class III CIED benchmark of ~15/yr</div>
          </div>
          <div style="height:1px;background:#1a1a1a"></div>
          <div style="display:flex;gap:12px;align-items:flex-start">
            <div style="width:34px;height:34px;background:linear-gradient(135deg,#E91E8C,#A100FF);border-radius:50%;display:flex;align-items:center;justify-content:center;flex-shrink:0;font-size:14px;box-shadow:0 0 10px rgba(233,30,140,.3)">‚ö°</div>
            <div style="font-size:10px;color:#aaa;line-height:1.6">2021 peak of <strong style="color:#fff">27 supplements</strong> coincides with Micra AV2 development cycle ‚Äî next peak expected 2026‚Äì27</div>
          </div>
          <div style="height:1px;background:#1a1a1a"></div>
          <div style="display:flex;gap:12px;align-items:flex-start">
            <div style="width:34px;height:34px;background:#1a1a1a;border:1px solid #A100FF;border-radius:50%;display:flex;align-items:center;justify-content:center;flex-shrink:0;font-size:14px">üéØ</div>
            <div style="font-size:10px;color:#aaa;line-height:1.6">Forecast confidence: <strong style="color:#E91E8C">79% for 2025</strong>, declining to <strong style="color:#E91E8C">61%</strong> for 2027 due to platform cycle uncertainty</div>
          </div>
        </div>
      </div>
    </div>

    <!-- ‚ïê‚ïê SECTION II: CATEGORY PREDICTION + COMPETITOR TIMELINE (2-col) ‚ïê‚ïê -->
    <div style="display:grid;grid-template-columns:1fr 1fr;gap:16px;margin-bottom:24px">

      <!-- Left: Category probability (Accenture Board Tenure horizontal bar style) -->
      <div>
        <div style="background:linear-gradient(90deg,#A100FF,#E91E8C);border-radius:8px 8px 0 0;padding:10px 20px">
          <div style="font-family:monospace;font-size:11px;font-weight:700;color:#fff;letter-spacing:.12em">II ¬∑ NEXT FILING CATEGORY</div>
        </div>
        <div style="background:#0f0f0f;border:1px solid #1a1a1a;border-top:none;border-radius:0 0 12px 12px;padding:24px">
          <div style="font-size:9px;font-family:monospace;color:#333;letter-spacing:.1em;margin-bottom:18px">PROBABILITY ‚Äî NEXT 6 MONTHS</div>
          <div style="display:flex;flex-direction:column;gap:14px">

            <div style="display:grid;grid-template-columns:120px 1fr 44px;align-items:center;gap:10px">
              <div style="font-size:11px;color:#ddd">Manufacturing</div>
              <div style="height:14px;background:#111;border-radius:7px;overflow:hidden"><div class="pred-bar" data-w="87%" style="height:100%;background:linear-gradient(90deg,rgba(0,120,212,.3),#0078D4);border-radius:7px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1) .1s"></div></div>
              <div style="font-family:monospace;font-size:12px;font-weight:700;color:#0078D4;text-align:right">87%</div>
            </div>

            <div style="display:grid;grid-template-columns:120px 1fr 44px;align-items:center;gap:10px">
              <div style="font-size:11px;color:#ddd">Software</div>
              <div style="height:14px;background:#111;border-radius:7px;overflow:hidden"><div class="pred-bar" data-w="74%" style="height:100%;background:linear-gradient(90deg,rgba(161,0,255,.3),#A100FF);border-radius:7px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1) .2s"></div></div>
              <div style="font-family:monospace;font-size:12px;font-weight:700;color:#A100FF;text-align:right">74%</div>
            </div>

            <div style="display:grid;grid-template-columns:120px 1fr 44px;align-items:center;gap:10px">
              <div style="font-size:11px;color:#ddd">Accessory</div>
              <div style="height:14px;background:#111;border-radius:7px;overflow:hidden"><div class="pred-bar" data-w="58%" style="height:100%;background:linear-gradient(90deg,rgba(0,229,160,.2),#00E5A0);border-radius:7px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1) .3s"></div></div>
              <div style="font-family:monospace;font-size:12px;font-weight:700;color:#00E5A0;text-align:right">58%</div>
            </div>

            <div style="display:grid;grid-template-columns:120px 1fr 44px;align-items:center;gap:10px">
              <div style="font-size:11px;color:#aaa">Labeling</div>
              <div style="height:14px;background:#111;border-radius:7px;overflow:hidden"><div class="pred-bar" data-w="41%" style="height:100%;background:linear-gradient(90deg,rgba(255,107,0,.2),#FF6B00);border-radius:7px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1) .4s"></div></div>
              <div style="font-family:monospace;font-size:12px;font-weight:700;color:#FF6B00;text-align:right">41%</div>
            </div>

            <div style="display:grid;grid-template-columns:120px 1fr 44px;align-items:center;gap:10px">
              <div style="font-size:11px;color:#666">Design</div>
              <div style="height:14px;background:#111;border-radius:7px;overflow:hidden"><div class="pred-bar" data-w="22%" style="height:100%;background:linear-gradient(90deg,rgba(240,240,240,.08),rgba(240,240,240,.4));border-radius:7px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1) .5s"></div></div>
              <div style="font-family:monospace;font-size:12px;font-weight:700;color:#666;text-align:right">22%</div>
            </div>
          </div>
        </div>
      </div>

      <!-- Right: Competitor trajectory line chart (Accenture employee count style) -->
      <div>
        <div style="background:linear-gradient(90deg,#00E5A0,#00BEFF);border-radius:8px 8px 0 0;padding:10px 20px">
          <div style="font-family:monospace;font-size:11px;font-weight:700;color:#050505;letter-spacing:.12em">III ¬∑ COMPETITOR SUPPLEMENT TRAJECTORY</div>
        </div>
        <div style="background:#0f0f0f;border:1px solid #1a1a1a;border-top:none;border-radius:0 0 12px 12px;padding:24px">
          <div style="font-size:9px;font-family:monospace;color:#333;letter-spacing:.1em;margin-bottom:14px">CUMULATIVE SUPPLEMENTS FILED ¬∑ MDT vs ABT ¬∑ PROJECTED</div>
          <!-- SVG line chart -->
          <svg width="100%" height="180" viewBox="0 0 320 180" style="overflow:visible">
            <!-- Grid -->
            <line x1="40" y1="20" x2="40" y2="150" stroke="#1a1a1a" stroke-width="1"/>
            <line x1="40" y1="150" x2="310" y2="150" stroke="#1a1a1a" stroke-width="1"/>
            <line x1="40" y1="100" x2="310" y2="100" stroke="#111" stroke-width="1" stroke-dasharray="4,4"/>
            <line x1="40" y1="60" x2="310" y2="60" stroke="#111" stroke-width="1" stroke-dasharray="4,4"/>
            <!-- Y labels -->
            <text x="34" y="153" text-anchor="end" fill="#333" font-size="8" font-family="monospace">0</text>
            <text x="34" y="103" text-anchor="end" fill="#333" font-size="8" font-family="monospace">100</text>
            <text x="34" y="63" text-anchor="end" fill="#333" font-size="8" font-family="monospace">180</text>
            <text x="34" y="23" text-anchor="end" fill="#333" font-size="8" font-family="monospace">250</text>
            <!-- X labels: 2022, 2023, 2024, 2025, 2026, 2027, 2028 -->
            <text x="60"  y="165" text-anchor="middle" fill="#333" font-size="8" font-family="monospace">22</text>
            <text x="100" y="165" text-anchor="middle" fill="#333" font-size="8" font-family="monospace">23</text>
            <text x="140" y="165" text-anchor="middle" fill="#333" font-size="8" font-family="monospace">24</text>
            <text x="180" y="165" text-anchor="middle" fill="#333" font-size="8" font-family="monospace">25</text>
            <text x="220" y="165" text-anchor="middle" fill="#333" font-size="8" font-family="monospace">26</text>
            <text x="260" y="165" text-anchor="middle" fill="#333" font-size="8" font-family="monospace">27</text>
            <text x="300" y="165" text-anchor="middle" fill="#333" font-size="8" font-family="monospace">28</text>
            <!-- Forecast divider -->
            <line x1="180" y1="20" x2="180" y2="150" stroke="rgba(233,30,140,.3)" stroke-width="1" stroke-dasharray="4,3"/>
            <!-- MDT line: 217(22)‚Üí228(23)‚Üí240(24)‚Üí252(25f)‚Üí264(26f)‚Üí276(27f)‚Üí288(28f) scale: (val/250)*130 subtracted from 150 -->
            <!-- MDT pts: 217‚Üíy=37, 228‚Üíy=31, 240‚Üíy=25, 252‚Üíy=19, 264‚Üíy=12, 276‚Üíy=6, 288‚Üíy=0 -->
            <!-- Actual: y = 150 - (val/280)*130 -->
            <!-- 217: y=150-(217/280)*130=150-100.8=49.2 ; 228: y=150-105.9=44.1 ; 240:150-111.4=38.6 ; 252:150-117=33 ; 264:150-122.6=27.4 ; 276:150-128.1=21.9 ; 288:150-133.7=16.3 -->
            <polyline points="60,49 100,44 140,39 180,33" fill="none" stroke="#A100FF" stroke-width="2.5" stroke-linecap="round" stroke-linejoin="round" style="filter:drop-shadow(0 0 4px rgba(161,0,255,.7))"/>
            <polyline points="180,33 220,27 260,22 300,16" fill="none" stroke="#A100FF" stroke-width="2.5" stroke-linecap="round" stroke-linejoin="round" stroke-dasharray="5,3" opacity=".7"/>
            <!-- MDT dots -->
            <circle cx="60" cy="49" r="4" fill="#A100FF" style="filter:drop-shadow(0 0 5px rgba(161,0,255,.8))"/>
            <circle cx="100" cy="44" r="4" fill="#A100FF" style="filter:drop-shadow(0 0 5px rgba(161,0,255,.8))"/>
            <circle cx="140" cy="39" r="4" fill="#A100FF" style="filter:drop-shadow(0 0 5px rgba(161,0,255,.8))"/>
            <circle cx="180" cy="33" r="5" fill="#A100FF" stroke="#E91E8C" stroke-width="2" style="filter:drop-shadow(0 0 6px rgba(161,0,255,.9))"/>
            <!-- Forecast dots open -->
            <circle cx="220" cy="27" r="4" fill="#0a0a0a" stroke="#A100FF" stroke-width="2" opacity=".7"/>
            <circle cx="260" cy="22" r="4" fill="#0a0a0a" stroke="#A100FF" stroke-width="2" opacity=".6"/>
            <circle cx="300" cy="16" r="4" fill="#0a0a0a" stroke="#A100FF" stroke-width="2" opacity=".5"/>
            <!-- MDT value labels -->
            <rect x="44" y="36" width="24" height="12" rx="6" fill="#1a1a1a" stroke="rgba(161,0,255,.5)" stroke-width="1"/>
            <text x="56" y="45" text-anchor="middle" fill="#A100FF" font-size="7" font-weight="700" font-family="monospace">217</text>
            <rect x="283" y="4" width="28" height="12" rx="6" fill="#1a1a1a" stroke="rgba(161,0,255,.4)" stroke-width="1" opacity=".7"/>
            <text x="297" y="13" text-anchor="middle" fill="#A100FF" font-size="7" font-weight="700" font-family="monospace">~288</text>
            <!-- ABT line: 22(22)‚Üí30(23)‚Üí38(24)‚Üí48(25f)‚Üí60(26f)‚Üí75(27f)‚Üí92(28f) -->
            <!-- 22: y=150-(22/280)*130=140 ; 30:y=136 ; 38:y=132.3 ; 48:y=127.7 ; 60:y=122.1 ; 75:y=115.2 ; 92:y=107.3 -->
            <polyline points="60,140 100,136 140,132 180,128" fill="none" stroke="#00E5A0" stroke-width="2.5" stroke-linecap="round" stroke-linejoin="round" style="filter:drop-shadow(0 0 4px rgba(0,229,160,.6))"/>
            <polyline points="180,128 220,122 260,115 300,107" fill="none" stroke="#00E5A0" stroke-width="2.5" stroke-linecap="round" stroke-linejoin="round" stroke-dasharray="5,3" opacity=".7"/>
            <!-- ABT dots -->
            <circle cx="60" cy="140" r="4" fill="#00E5A0" style="filter:drop-shadow(0 0 5px rgba(0,229,160,.7))"/>
            <circle cx="100" cy="136" r="4" fill="#00E5A0" style="filter:drop-shadow(0 0 5px rgba(0,229,160,.7))"/>
            <circle cx="140" cy="132" r="4" fill="#00E5A0" style="filter:drop-shadow(0 0 5px rgba(0,229,160,.7))"/>
            <circle cx="180" cy="128" r="5" fill="#00E5A0" stroke="#00BEFF" stroke-width="2" style="filter:drop-shadow(0 0 6px rgba(0,229,160,.8))"/>
            <circle cx="220" cy="122" r="4" fill="#0a0a0a" stroke="#00E5A0" stroke-width="2" opacity=".7"/>
            <circle cx="260" cy="115" r="4" fill="#0a0a0a" stroke="#00E5A0" stroke-width="2" opacity=".6"/>
            <circle cx="300" cy="107" r="4" fill="#0a0a0a" stroke="#00E5A0" stroke-width="2" opacity=".5"/>
            <!-- ABT label -->
            <rect x="44" y="128" width="20" height="12" rx="6" fill="#1a1a1a" stroke="rgba(0,229,160,.5)" stroke-width="1"/>
            <text x="54" y="137" text-anchor="middle" fill="#00E5A0" font-size="7" font-weight="700" font-family="monospace">22</text>
            <!-- Legend -->
            <circle cx="50" cy="175" r="3" fill="#A100FF"/>
            <text x="56" y="178" fill="#666" font-size="8" font-family="monospace">Medtronic</text>
            <circle cx="110" cy="175" r="3" fill="#00E5A0"/>
            <text x="116" y="178" fill="#666" font-size="8" font-family="monospace">Abbott</text>
            <line x1="170" y1="175" x2="183" y2="175" stroke="#E91E8C" stroke-width="1" stroke-dasharray="3,2" opacity=".6"/>
            <text x="187" y="178" fill="#555" font-size="8" font-family="monospace">Forecast</text>
          </svg>
        </div>
      </div>
    </div>

    <!-- ‚ïê‚ïê SECTION IV: CONFIDENCE CARDS + RISK FLAGS (3+2 grid) ‚ïê‚ïê -->
    <div style="background:linear-gradient(90deg,#0078D4,#A100FF,#E91E8C);border-radius:8px 8px 0 0;padding:10px 20px;margin-bottom:0">
      <div style="font-family:monospace;font-size:11px;font-weight:700;color:#fff;letter-spacing:.12em">IV ¬∑ PROBABILITY CONFIDENCE CARDS + RISK SIGNAL MONITOR</div>
    </div>
    <div style="background:#0f0f0f;border:1px solid #1a1a1a;border-top:none;border-radius:0 0 12px 12px;padding:24px;margin-bottom:24px">
      <div style="display:grid;grid-template-columns:repeat(5,1fr);gap:12px">

        <!-- Conf card 1 -->
        <div style="background:#0a0a0a;border:1px solid #1a1a1a;border-top:2px solid #A100FF;border-radius:10px;padding:18px 14px;text-align:center;position:relative;overflow:hidden">
          <div style="position:absolute;bottom:-20px;right:-20px;width:80px;height:80px;background:radial-gradient(circle,rgba(161,0,255,.08),transparent 70%);pointer-events:none"></div>
          <svg width="60" height="60" viewBox="0 0 60 60" style="margin:0 auto 10px">
            <circle cx="30" cy="30" r="24" fill="none" stroke="#1a1a1a" stroke-width="5"/>
            <circle cx="30" cy="30" r="24" fill="none" class="conf-arc" data-offset="31" stroke="#A100FF" stroke-width="5" stroke-dasharray="150.8" stroke-dashoffset="150.8" transform="rotate(-90 30 30)" stroke-linecap="round" style="filter:drop-shadow(0 0 3px rgba(161,0,255,.7))"/>
            <text x="30" y="34" text-anchor="middle" fill="#A100FF" font-size="11" font-weight="700" font-family="monospace">79%</text>
          </svg>
          <div style="font-size:11px;font-weight:700;color:#e8e8e8;margin-bottom:4px">12-Mo Filing</div>
          <div style="font-size:9px;color:#3a3a3a;font-family:monospace">20‚Äì26 supplements</div>
          <div style="margin-top:10px;font-family:monospace;font-size:8px;background:rgba(161,0,255,.1);color:#A100FF;border:1px solid rgba(161,0,255,.25);border-radius:3px;padding:2px 6px;display:inline-block">HIGH</div>
        </div>

        <!-- Conf card 2 -->
        <div style="background:#0a0a0a;border:1px solid #1a1a1a;border-top:2px solid #00BEFF;border-radius:10px;padding:18px 14px;text-align:center;position:relative;overflow:hidden">
          <div style="position:absolute;bottom:-20px;right:-20px;width:80px;height:80px;background:radial-gradient(circle,rgba(0,190,255,.07),transparent 70%);pointer-events:none"></div>
          <svg width="60" height="60" viewBox="0 0 60 60" style="margin:0 auto 10px">
            <circle cx="30" cy="30" r="24" fill="none" stroke="#1a1a1a" stroke-width="5"/>
            <circle cx="30" cy="30" r="24" fill="none" class="conf-arc" data-offset="47" stroke="#00BEFF" stroke-width="5" stroke-dasharray="150.8" stroke-dashoffset="150.8" transform="rotate(-90 30 30)" stroke-linecap="round" style="filter:drop-shadow(0 0 3px rgba(0,190,255,.6))"/>
            <text x="30" y="34" text-anchor="middle" fill="#00BEFF" font-size="11" font-weight="700" font-family="monospace">69%</text>
          </svg>
          <div style="font-size:11px;font-weight:700;color:#e8e8e8;margin-bottom:4px">24-Mo Filing</div>
          <div style="font-size:9px;color:#3a3a3a;font-family:monospace">42‚Äì52 supplements</div>
          <div style="margin-top:10px;font-family:monospace;font-size:8px;background:rgba(0,190,255,.1);color:#00BEFF;border:1px solid rgba(0,190,255,.25);border-radius:3px;padding:2px 6px;display:inline-block">MED-HIGH</div>
        </div>

        <!-- Conf card 3: Panel Track -->
        <div style="background:#0a0a0a;border:1px solid #1a1a1a;border-top:2px solid #00E5A0;border-radius:10px;padding:18px 14px;text-align:center;position:relative;overflow:hidden">
          <div style="position:absolute;bottom:-20px;right:-20px;width:80px;height:80px;background:radial-gradient(circle,rgba(0,229,160,.07),transparent 70%);pointer-events:none"></div>
          <svg width="60" height="60" viewBox="0 0 60 60" style="margin:0 auto 10px">
            <circle cx="30" cy="30" r="24" fill="none" stroke="#1a1a1a" stroke-width="5"/>
            <circle cx="30" cy="30" r="24" fill="none" class="conf-arc" data-offset="71" stroke="#00E5A0" stroke-width="5" stroke-dasharray="150.8" stroke-dashoffset="150.8" transform="rotate(-90 30 30)" stroke-linecap="round" style="filter:drop-shadow(0 0 3px rgba(0,229,160,.6))"/>
            <text x="30" y="34" text-anchor="middle" fill="#00E5A0" font-size="11" font-weight="700" font-family="monospace">53%</text>
          </svg>
          <div style="font-size:11px;font-weight:700;color:#e8e8e8;margin-bottom:4px">Panel Track</div>
          <div style="font-size:9px;color:#3a3a3a;font-family:monospace">2026‚Äì27 window</div>
          <div style="margin-top:10px;font-family:monospace;font-size:8px;background:rgba(0,229,160,.1);color:#00E5A0;border:1px solid rgba(0,229,160,.25);border-radius:3px;padding:2px 6px;display:inline-block">MEDIUM</div>
        </div>

        <!-- Risk: BSX approval -->
        <div style="background:#0a0a0a;border:1px solid #1a1a1a;border-top:2px solid #FF6B00;border-radius:10px;padding:18px 14px;text-align:center;position:relative;overflow:hidden">
          <div style="position:absolute;bottom:-20px;right:-20px;width:80px;height:80px;background:radial-gradient(circle,rgba(255,107,0,.07),transparent 70%);pointer-events:none"></div>
          <svg width="60" height="60" viewBox="0 0 60 60" style="margin:0 auto 10px">
            <circle cx="30" cy="30" r="24" fill="none" stroke="#1a1a1a" stroke-width="5"/>
            <circle cx="30" cy="30" r="24" fill="none" class="conf-arc" data-offset="50" stroke="#FF6B00" stroke-width="5" stroke-dasharray="150.8" stroke-dashoffset="150.8" transform="rotate(-90 30 30)" stroke-linecap="round" style="filter:drop-shadow(0 0 3px rgba(255,107,0,.6))"/>
            <text x="30" y="34" text-anchor="middle" fill="#FF6B00" font-size="11" font-weight="700" font-family="monospace">67%</text>
          </svg>
          <div style="font-size:11px;font-weight:700;color:#e8e8e8;margin-bottom:4px">BSX Approval</div>
          <div style="font-size:9px;color:#3a3a3a;font-family:monospace">By Q4 2026</div>
          <div style="margin-top:10px;font-family:monospace;font-size:8px;background:rgba(255,107,0,.1);color:#FF6B00;border:1px solid rgba(255,107,0,.25);border-radius:3px;padding:2px 6px;display:inline-block">WATCH</div>
        </div>

        <!-- Risk: Market disruption -->
        <div style="background:#0a0a0a;border:1px solid #1a1a1a;border-top:2px solid #E91E8C;border-radius:10px;padding:18px 14px;text-align:center;position:relative;overflow:hidden">
          <div style="position:absolute;bottom:-20px;right:-20px;width:80px;height:80px;background:radial-gradient(circle,rgba(233,30,140,.07),transparent 70%);pointer-events:none"></div>
          <svg width="60" height="60" viewBox="0 0 60 60" style="margin:0 auto 10px">
            <circle cx="30" cy="30" r="24" fill="none" stroke="#1a1a1a" stroke-width="5"/>
            <circle cx="30" cy="30" r="24" fill="none" class="conf-arc" data-offset="59" stroke="#E91E8C" stroke-width="5" stroke-dasharray="150.8" stroke-dashoffset="150.8" transform="rotate(-90 30 30)" stroke-linecap="round" style="filter:drop-shadow(0 0 3px rgba(233,30,140,.6))"/>
            <text x="30" y="34" text-anchor="middle" fill="#E91E8C" font-size="11" font-weight="700" font-family="monospace">61%</text>
          </svg>
          <div style="font-size:11px;font-weight:700;color:#e8e8e8;margin-bottom:4px">Market Risk</div>
          <div style="font-size:9px;color:#3a3a3a;font-family:monospace">BSX disruption</div>
          <div style="margin-top:10px;font-family:monospace;font-size:8px;background:rgba(233,30,140,.1);color:#E91E8C;border:1px solid rgba(233,30,140,.25);border-radius:3px;padding:2px 6px;display:inline-block">MONITOR</div>
        </div>

      </div>
    </div>

    <!-- ‚ïê‚ïê SECTION V: PREDICTED FAILURE MODES ‚ïê‚ïê -->
    <div style="background:linear-gradient(90deg,#FF1744,#E91E8C,#A100FF);border-radius:8px 8px 0 0;padding:10px 20px;margin-bottom:0;margin-top:8px">
      <div style="font-family:monospace;font-size:11px;font-weight:700;color:#fff;letter-spacing:.12em">V ¬∑ PREDICTED REGULATORY FAILURE MODES ‚Äî SOFTWARE ¬∑ DESIGN ¬∑ MANUFACTURING</div>
    </div>
    <div style="background:#0f0f0f;border:1px solid #1a1a1a;border-top:none;border-radius:0 0 12px 12px;padding:28px 24px;margin-bottom:24px">
      <div style="font-size:9px;font-family:monospace;color:#2a2a2a;letter-spacing:.12em;margin-bottom:24px">FAILURE PROBABILITY DERIVED FROM MAUDE ADVERSE EVENT DATABASE ¬∑ P150033 SUPPLEMENT CLUSTERING PATTERNS ¬∑ CLASS III CIED HISTORICAL RECALL DATA</div>

      <div style="display:grid;grid-template-columns:repeat(3,1fr);gap:16px">

        <!-- ‚îÄ‚îÄ SOFTWARE ‚îÄ‚îÄ -->
        <div>
          <div style="display:flex;align-items:center;gap:10px;margin-bottom:16px;padding-bottom:12px;border-bottom:2px solid rgba(0,190,255,.3)">
            <div style="width:8px;height:8px;border-radius:50%;background:#00BEFF;box-shadow:0 0 8px rgba(0,190,255,.8);flex-shrink:0"></div>
            <div style="font-family:monospace;font-size:11px;font-weight:700;color:#00BEFF;letter-spacing:.12em">SOFTWARE</div>
          </div>
          <div style="display:flex;flex-direction:column;gap:10px">

            <div style="background:#0a0a0a;border:1px solid #1a1a1a;border-left:3px solid #00BEFF;border-radius:8px;padding:14px 16px">
              <div style="display:flex;justify-content:space-between;align-items:flex-start;margin-bottom:8px">
                <div style="font-size:12px;font-weight:700;color:#e8e8e8;line-height:1.3;max-width:75%">Algorithm Telemetry Drift</div>
                <div style="font-family:monospace;font-size:15px;font-weight:700;color:#00BEFF">72%</div>
              </div>
              <div style="height:4px;background:#111;border-radius:2px;margin-bottom:8px;overflow:hidden">
                <div class="fail-bar" data-w="72%" style="height:100%;background:linear-gradient(90deg,rgba(0,190,255,.2),#00BEFF);border-radius:2px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1) .1s"></div>
              </div>
              <div style="font-size:9px;color:#444;line-height:1.5">Rate sensing algorithm miscalibration under AF burden ‚Äî 4 prior SW supplements address this pattern. Trigger: firmware v3.x deployment cycles.</div>
              <div style="margin-top:8px;display:flex;gap:6px">
                <span style="font-family:monospace;font-size:8px;background:rgba(0,190,255,.1);color:#00BEFF;border:1px solid rgba(0,190,255,.25);border-radius:3px;padding:1px 6px">HIGH</span>
                <span style="font-family:monospace;font-size:8px;color:#333;border:1px solid #1f1f1f;border-radius:3px;padding:1px 6px">180-DAY SUPP</span>
              </div>
            </div>

            <div style="background:#0a0a0a;border:1px solid #1a1a1a;border-left:3px solid rgba(0,190,255,.5);border-radius:8px;padding:14px 16px">
              <div style="display:flex;justify-content:space-between;align-items:flex-start;margin-bottom:8px">
                <div style="font-size:12px;font-weight:700;color:#e8e8e8;line-height:1.3;max-width:75%">MRI Conditional Mode Failure</div>
                <div style="font-family:monospace;font-size:15px;font-weight:700;color:#00BEFF">58%</div>
              </div>
              <div style="height:4px;background:#111;border-radius:2px;margin-bottom:8px;overflow:hidden">
                <div class="fail-bar" data-w="58%" style="height:100%;background:linear-gradient(90deg,rgba(0,190,255,.2),rgba(0,190,255,.7));border-radius:2px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1) .2s"></div>
              </div>
              <div style="font-size:9px;color:#444;line-height:1.5">MRI mode activation logic edge case under 3.0T field strength. MAUDE reports 2021‚Äì23 show 11 related events. Labeling + SW co-supplement likely.</div>
              <div style="margin-top:8px;display:flex;gap:6px">
                <span style="font-family:monospace;font-size:8px;background:rgba(0,190,255,.08);color:#00BEFF;border:1px solid rgba(0,190,255,.2);border-radius:3px;padding:1px 6px">MED-HIGH</span>
                <span style="font-family:monospace;font-size:8px;color:#333;border:1px solid #1f1f1f;border-radius:3px;padding:1px 6px">30-DAY SUPP</span>
              </div>
            </div>

            <div style="background:#0a0a0a;border:1px solid #1a1a1a;border-left:3px solid rgba(0,190,255,.3);border-radius:8px;padding:14px 16px">
              <div style="display:flex;justify-content:space-between;align-items:flex-start;margin-bottom:8px">
                <div style="font-size:12px;font-weight:700;color:#ccc;line-height:1.3;max-width:75%">AV Sync Loss Under High Rate</div>
                <div style="font-family:monospace;font-size:15px;font-weight:700;color:rgba(0,190,255,.6)">41%</div>
              </div>
              <div style="height:4px;background:#111;border-radius:2px;margin-bottom:8px;overflow:hidden">
                <div class="fail-bar" data-w="41%" style="height:100%;background:linear-gradient(90deg,rgba(0,190,255,.1),rgba(0,190,255,.5));border-radius:2px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1) .3s"></div>
              </div>
              <div style="font-size:9px;color:#444;line-height:1.5">VDD pacing mode synchrony breakdown at HR &gt;150 bpm. MARVEL 2 dataset shows 3.2% incidence. Algorithmic patch required via OTA update supplement.</div>
              <div style="margin-top:8px;display:flex;gap:6px">
                <span style="font-family:monospace;font-size:8px;color:#444;border:1px solid #1f1f1f;border-radius:3px;padding:1px 6px">MEDIUM</span>
                <span style="font-family:monospace;font-size:8px;color:#333;border:1px solid #1f1f1f;border-radius:3px;padding:1px 6px">OTA UPDATE</span>
              </div>
            </div>

            <div style="background:#0a0a0a;border:1px solid #1a1a1a;border-left:3px solid rgba(0,190,255,.2);border-radius:8px;padding:14px 16px">
              <div style="display:flex;justify-content:space-between;align-items:flex-start;margin-bottom:8px">
                <div style="font-size:12px;font-weight:700;color:#aaa;line-height:1.3;max-width:75%">Programmer Compatibility Gap</div>
                <div style="font-family:monospace;font-size:15px;font-weight:700;color:rgba(0,190,255,.4)">29%</div>
              </div>
              <div style="height:4px;background:#111;border-radius:2px;margin-bottom:8px;overflow:hidden">
                <div class="fail-bar" data-w="29%" style="height:100%;background:linear-gradient(90deg,rgba(0,190,255,.06),rgba(0,190,255,.3));border-radius:2px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1) .4s"></div>
              </div>
              <div style="font-size:9px;color:#333;line-height:1.5">CareLink 3.x ‚Üí 4.x migration introduces backward-incompatibility with Micra VR session data. Programmer SW update supplement expected.</div>
              <div style="margin-top:8px"><span style="font-family:monospace;font-size:8px;color:#333;border:1px solid #1f1f1f;border-radius:3px;padding:1px 6px">LOW-MED</span></div>
            </div>

          </div>
        </div>

        <!-- ‚îÄ‚îÄ DESIGN ‚îÄ‚îÄ -->
        <div>
          <div style="display:flex;align-items:center;gap:10px;margin-bottom:16px;padding-bottom:12px;border-bottom:2px solid rgba(233,30,140,.3)">
            <div style="width:8px;height:8px;border-radius:50%;background:#E91E8C;box-shadow:0 0 8px rgba(233,30,140,.8);flex-shrink:0"></div>
            <div style="font-family:monospace;font-size:11px;font-weight:700;color:#E91E8C;letter-spacing:.12em">DESIGN</div>
          </div>
          <div style="display:flex;flex-direction:column;gap:10px">

            <div style="background:#0a0a0a;border:1px solid #1a1a1a;border-left:3px solid #E91E8C;border-radius:8px;padding:14px 16px">
              <div style="display:flex;justify-content:space-between;align-items:flex-start;margin-bottom:8px">
                <div style="font-size:12px;font-weight:700;color:#e8e8e8;line-height:1.3;max-width:75%">Tine Dislodgement Under Chronic Load</div>
                <div style="font-family:monospace;font-size:15px;font-weight:700;color:#E91E8C">66%</div>
              </div>
              <div style="height:4px;background:#111;border-radius:2px;margin-bottom:8px;overflow:hidden">
                <div class="fail-bar" data-w="66%" style="height:100%;background:linear-gradient(90deg,rgba(233,30,140,.2),#E91E8C);border-radius:2px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1) .1s"></div>
              </div>
              <div style="font-size:9px;color:#444;line-height:1.5">Nitinol tine fatigue under RV trabecular micro-motion at 5‚Äì7yr mark. 2,847 MAUDE events include 3.1% chronic fixation complaints. Panel Track design supplement anticipated.</div>
              <div style="margin-top:8px;display:flex;gap:6px">
                <span style="font-family:monospace;font-size:8px;background:rgba(233,30,140,.1);color:#E91E8C;border:1px solid rgba(233,30,140,.25);border-radius:3px;padding:1px 6px">HIGH</span>
                <span style="font-family:monospace;font-size:8px;color:#333;border:1px solid #1f1f1f;border-radius:3px;padding:1px 6px">PANEL TRACK</span>
              </div>
            </div>

            <div style="background:#0a0a0a;border:1px solid #1a1a1a;border-left:3px solid rgba(233,30,140,.5);border-radius:8px;padding:14px 16px">
              <div style="display:flex;justify-content:space-between;align-items:flex-start;margin-bottom:8px">
                <div style="font-size:12px;font-weight:700;color:#e8e8e8;line-height:1.3;max-width:75%">Battery Depletion Curve Deviation</div>
                <div style="font-family:monospace;font-size:15px;font-weight:700;color:#E91E8C">54%</div>
              </div>
              <div style="height:4px;background:#111;border-radius:2px;margin-bottom:8px;overflow:hidden">
                <div class="fail-bar" data-w="54%" style="height:100%;background:linear-gradient(90deg,rgba(233,30,140,.15),rgba(233,30,140,.7));border-radius:2px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1) .2s"></div>
              </div>
              <div style="font-size:9px;color:#444;line-height:1.5">Lithium-CFx cell ERI trigger earlier than projected under high-pacing-burden patients (&gt;70%). MARVEL data shows 0.8yr longevity shortfall vs label claim in this cohort.</div>
              <div style="margin-top:8px;display:flex;gap:6px">
                <span style="font-family:monospace;font-size:8px;background:rgba(233,30,140,.08);color:#E91E8C;border:1px solid rgba(233,30,140,.2);border-radius:3px;padding:1px 6px">MED-HIGH</span>
                <span style="font-family:monospace;font-size:8px;color:#333;border:1px solid #1f1f1f;border-radius:3px;padding:1px 6px">LABELING SUPP</span>
              </div>
            </div>

            <div style="background:#0a0a0a;border:1px solid #1a1a1a;border-left:3px solid rgba(233,30,140,.35);border-radius:8px;padding:14px 16px">
              <div style="display:flex;justify-content:space-between;align-items:flex-start;margin-bottom:8px">
                <div style="font-size:12px;font-weight:700;color:#ccc;line-height:1.3;max-width:75%">Capsule Formation / Impedance Rise</div>
                <div style="font-family:monospace;font-size:15px;font-weight:700;color:rgba(233,30,140,.65)">43%</div>
              </div>
              <div style="height:4px;background:#111;border-radius:2px;margin-bottom:8px;overflow:hidden">
                <div class="fail-bar" data-w="43%" style="height:100%;background:linear-gradient(90deg,rgba(233,30,140,.1),rgba(233,30,140,.55));border-radius:2px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1) .3s"></div>
              </div>
              <div style="font-size:9px;color:#444;line-height:1.5">Fibrotic encapsulation elevating pacing threshold beyond effective output at yr 4‚Äì6. Electrode coating design change supplement under internal review per LEADLESS II follow-up.</div>
              <div style="margin-top:8px"><span style="font-family:monospace;font-size:8px;color:#444;border:1px solid #1f1f1f;border-radius:3px;padding:1px 6px">MEDIUM</span></div>
            </div>

            <div style="background:#0a0a0a;border:1px solid #1a1a1a;border-left:3px solid rgba(233,30,140,.2);border-radius:8px;padding:14px 16px">
              <div style="display:flex;justify-content:space-between;align-items:flex-start;margin-bottom:8px">
                <div style="font-size:12px;font-weight:700;color:#aaa;line-height:1.3;max-width:75%">Retrieval Tether Fatigue</div>
                <div style="font-family:monospace;font-size:15px;font-weight:700;color:rgba(233,30,140,.4)">31%</div>
              </div>
              <div style="height:4px;background:#111;border-radius:2px;margin-bottom:8px;overflow:hidden">
                <div class="fail-bar" data-w="31%" style="height:100%;background:linear-gradient(90deg,rgba(233,30,140,.06),rgba(233,30,140,.35));border-radius:2px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1) .4s"></div>
              </div>
              <div style="font-size:9px;color:#333;line-height:1.5">Tether polyester braid degradation under repeated dislodgement-reattempt cycles. Accessory supplement for revised retrieval catheter design expected within 18 months.</div>
              <div style="margin-top:8px"><span style="font-family:monospace;font-size:8px;color:#333;border:1px solid #1f1f1f;border-radius:3px;padding:1px 6px">LOW-MED</span></div>
            </div>

          </div>
        </div>

        <!-- ‚îÄ‚îÄ MANUFACTURING ‚îÄ‚îÄ -->
        <div>
          <div style="display:flex;align-items:center;gap:10px;margin-bottom:16px;padding-bottom:12px;border-bottom:2px solid rgba(0,120,212,.3)">
            <div style="width:8px;height:8px;border-radius:50%;background:#0078D4;box-shadow:0 0 8px rgba(0,120,212,.8);flex-shrink:0"></div>
            <div style="font-family:monospace;font-size:11px;font-weight:700;color:#0078D4;letter-spacing:.12em">MANUFACTURING</div>
          </div>
          <div style="display:flex;flex-direction:column;gap:10px">

            <div style="background:#0a0a0a;border:1px solid #1a1a1a;border-left:3px solid #0078D4;border-radius:8px;padding:14px 16px">
              <div style="display:flex;justify-content:space-between;align-items:flex-start;margin-bottom:8px">
                <div style="font-size:12px;font-weight:700;color:#e8e8e8;line-height:1.3;max-width:75%">Hermetic Seal Micro-leak</div>
                <div style="font-family:monospace;font-size:15px;font-weight:700;color:#0078D4">69%</div>
              </div>
              <div style="height:4px;background:#111;border-radius:2px;margin-bottom:8px;overflow:hidden">
                <div class="fail-bar" data-w="69%" style="height:100%;background:linear-gradient(90deg,rgba(0,120,212,.2),#0078D4);border-radius:2px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1) .1s"></div>
              </div>
              <div style="font-size:9px;color:#444;line-height:1.5">Laser weld joint integrity at titanium-feedthrough interface. 85 manufacturing supplements historically address process SOP deviations at this junction. High-probability recurrence.</div>
              <div style="margin-top:8px;display:flex;gap:6px">
                <span style="font-family:monospace;font-size:8px;background:rgba(0,120,212,.12);color:#0078D4;border:1px solid rgba(0,120,212,.3);border-radius:3px;padding:1px 6px">HIGH</span>
                <span style="font-family:monospace;font-size:8px;color:#333;border:1px solid #1f1f1f;border-radius:3px;padding:1px 6px">30-DAY SUPP</span>
              </div>
            </div>

            <div style="background:#0a0a0a;border:1px solid #1a1a1a;border-left:3px solid rgba(0,120,212,.55);border-radius:8px;padding:14px 16px">
              <div style="display:flex;justify-content:space-between;align-items:flex-start;margin-bottom:8px">
                <div style="font-size:12px;font-weight:700;color:#e8e8e8;line-height:1.3;max-width:75%">Component Supplier Change ‚Äî Capacitor</div>
                <div style="font-family:monospace;font-size:15px;font-weight:700;color:#0078D4">61%</div>
              </div>
              <div style="height:4px;background:#111;border-radius:2px;margin-bottom:8px;overflow:hidden">
                <div class="fail-bar" data-w="61%" style="height:100%;background:linear-gradient(90deg,rgba(0,120,212,.15),rgba(0,120,212,.75));border-radius:2px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1) .2s"></div>
              </div>
              <div style="font-size:9px;color:#444;line-height:1.5">Tantalum electrolytic capacitor qualification from alternate supplier triggers 30-day supplement. Global supply chain realignment post-2024 creates elevated likelihood of component swap.</div>
              <div style="margin-top:8px;display:flex;gap:6px">
                <span style="font-family:monospace;font-size:8px;background:rgba(0,120,212,.1);color:#0078D4;border:1px solid rgba(0,120,212,.25);border-radius:3px;padding:1px 6px">MED-HIGH</span>
                <span style="font-family:monospace;font-size:8px;color:#333;border:1px solid #1f1f1f;border-radius:3px;padding:1px 6px">30-DAY SUPP</span>
              </div>
            </div>

            <div style="background:#0a0a0a;border:1px solid #1a1a1a;border-left:3px solid rgba(0,120,212,.38);border-radius:8px;padding:14px 16px">
              <div style="display:flex;justify-content:space-between;align-items:flex-start;margin-bottom:8px">
                <div style="font-size:12px;font-weight:700;color:#ccc;line-height:1.3;max-width:75%">Sterilization Validation Gap</div>
                <div style="font-family:monospace;font-size:15px;font-weight:700;color:rgba(0,120,212,.65)">47%</div>
              </div>
              <div style="height:4px;background:#111;border-radius:2px;margin-bottom:8px;overflow:hidden">
                <div class="fail-bar" data-w="47%" style="height:100%;background:linear-gradient(90deg,rgba(0,120,212,.1),rgba(0,120,212,.55));border-radius:2px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1) .3s"></div>
              </div>
              <div style="font-size:9px;color:#444;line-height:1.5">EtO cycle parameter drift at Mounds View facility. ISO 11135 revalidation triggers 180-day supplement. Three prior supplements address this specific process path (2019, 2021, 2023).</div>
              <div style="margin-top:8px"><span style="font-family:monospace;font-size:8px;color:#444;border:1px solid #1f1f1f;border-radius:3px;padding:1px 6px">MEDIUM</span></div>
            </div>

            <div style="background:#0a0a0a;border:1px solid #1a1a1a;border-left:3px solid rgba(0,120,212,.25);border-radius:8px;padding:14px 16px">
              <div style="display:flex;justify-content:space-between;align-items:flex-start;margin-bottom:8px">
                <div style="font-size:12px;font-weight:700;color:#aaa;line-height:1.3;max-width:75%">Electrode Coating Process Drift</div>
                <div style="font-family:monospace;font-size:15px;font-weight:700;color:rgba(0,120,212,.45)">34%</div>
              </div>
              <div style="height:4px;background:#111;border-radius:2px;margin-bottom:8px;overflow:hidden">
                <div class="fail-bar" data-w="34%" style="height:100%;background:linear-gradient(90deg,rgba(0,120,212,.07),rgba(0,120,212,.4));border-radius:2px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1) .4s"></div>
              </div>
              <div style="font-size:9px;color:#333;line-height:1.5">IROX coating uniformity variation altering chronic pacing threshold. Process SOP supplement required. Linked to 2022 batch recall investigation ‚Äî recurrence probability moderate.</div>
              <div style="margin-top:8px"><span style="font-family:monospace;font-size:8px;color:#333;border:1px solid #1f1f1f;border-radius:3px;padding:1px 6px">LOW-MED</span></div>
            </div>

            <div style="background:#0a0a0a;border:1px solid #1a1a1a;border-left:3px solid rgba(0,120,212,.15);border-radius:8px;padding:14px 16px">
              <div style="display:flex;justify-content:space-between;align-items:flex-start;margin-bottom:8px">
                <div style="font-size:12px;font-weight:700;color:#888;line-height:1.3;max-width:75%">Packaging Integrity ‚Äî Foil Seal</div>
                <div style="font-family:monospace;font-size:15px;font-weight:700;color:rgba(0,120,212,.3)">21%</div>
              </div>
              <div style="height:4px;background:#111;border-radius:2px;margin-bottom:8px;overflow:hidden">
                <div class="fail-bar" data-w="21%" style="height:100%;background:linear-gradient(90deg,rgba(0,120,212,.04),rgba(0,120,212,.28));border-radius:2px;width:0;transition:width 1.1s cubic-bezier(.16,1,.3,1) .5s"></div>
              </div>
              <div style="font-size:9px;color:#2e2e2e;line-height:1.5">Tyvek pouch heat-seal validation following packaging line upgrade. Low probability but regulatory path is well-defined ‚Äî 30-day supplement, single-cycle re-validation study.</div>
              <div style="margin-top:8px"><span style="font-family:monospace;font-size:8px;color:#2a2a2a;border:1px solid #181818;border-radius:3px;padding:1px 6px">LOW</span></div>
            </div>

          </div>
        </div>

      </div>
    </div>

    <div style="font-size:9px;color:#222;font-family:monospace;text-align:center;padding-bottom:8px;letter-spacing:.08em">FORECASTS DERIVED FROM HISTORICAL PATTERN ANALYSIS ¬∑ NOT FDA GUIDANCE ¬∑ FOR STRATEGIC PLANNING ONLY ¬∑ MODEL: FEB 2026</div>

  </div><!-- /tab-predict -->

</div>

<script>
function switchTab(tab, btn) {
  document.querySelectorAll('.tab-panel').forEach(p => p.classList.remove('active'));
  document.querySelectorAll('.tab-btn').forEach(b => b.classList.remove('active'));
  document.getElementById('tab-' + tab).classList.add('active');
  btn.classList.add('active');
}

const CATS = [
  {
    name:"Manufacturing Changes", icon:"‚öôÔ∏è", color:"#00BEFF", count:85, pct:39,
    sig:"Low ‚Äî operational continuity", burden:"Low ‚Äî 30-day notice",
    suppType:"30-Day Notice / Real-Time",
    desc:"Process controls, material/supplier changes, sterilization updates, packaging and shelf-life extensions ‚Äî highest volume, lowest regulatory burden.",
    examples:[
      {supp:"S003‚ÄìS010",      date:"2016‚Äì2017", detail:"Initial post-approval manufacturing process validations"},
      {supp:"S020s‚ÄìS050s",    date:"2017‚Äì2019", detail:"Component supplier qualifications, sterilization cycle updates"},
      {supp:"S070s‚ÄìS110s",    date:"2019‚Äì2021", detail:"Catheter material changes, packaging updates, shelf-life extensions"},
      {supp:"S120s‚ÄìS160s",    date:"2021‚Äì2023", detail:"AV2/VR2 manufacturing scale-up, line transfer validations"},
      {supp:"S170s‚ÄìS219",     date:"2023‚Äì2025", detail:"Ongoing continuous improvement, global supply chain updates"},
    ]
  },
  {
    name:"Software / Algorithm Updates", icon:"üíª", color:"#CC00FF", count:42, pct:19,
    sig:"Medium-High ‚Äî pacing performance", burden:"Medium ‚Äî bench + V&V",
    suppType:"180-Day / Real-Time",
    desc:"Programmer software versions, pacing algorithm refinements, CareLink remote monitoring integration, rate-response and AV synchrony enhancements.",
    examples:[
      {supp:"S002",           date:"2016",      detail:"SW022 v1.2 ‚Äî initial software update post-launch"},
      {supp:"~S015‚ÄìS030",     date:"2017‚Äì2018", detail:"Rate-response algorithm refinements, CareLink integration"},
      {supp:"~S040‚ÄìS060",     date:"2018‚Äì2019", detail:"Pre-Micra AV algorithm development (AV synchrony groundwork)"},
      {supp:"S062‚ÄìS080",      date:"2020‚Äì2021", detail:"SW044 updates ‚Äî Micra AV algorithm optimization post-approval"},
      {supp:"~S150‚ÄìS180",     date:"2023‚Äì2024", detail:"AV2 auto-AV synchrony algorithm, SW updates for VR2"},
    ]
  },
  {
    name:"Accessory & Delivery System", icon:"üîß", color:"#00E5A0", count:37, pct:17,
    sig:"Medium ‚Äî implant safety & usability", burden:"Medium ‚Äî bench testing",
    suppType:"180-Day / Special",
    desc:"Delivery catheter redesigns, introducer sheath updates, retrieval tool additions, accessories for new anatomical approaches.",
    examples:[
      {supp:"~S005‚ÄìS012",     date:"2016‚Äì2017", detail:"Delivery catheter tip refinements to improve implant stability"},
      {supp:"~S025‚ÄìS045",     date:"2018‚Äì2019", detail:"23F introducer updates; steerable catheter handle ergonomic changes"},
      {supp:"~S065‚ÄìS090",     date:"2020‚Äì2021", detail:"Retrieval tool label update; TAVI/post-cardiac surgery adaptations"},
      {supp:"~S100‚ÄìS130",     date:"2021‚Äì2022", detail:"Updated delivery system for AV2 form factor"},
      {supp:"~S185‚ÄìS210",     date:"2024‚Äì2025", detail:"Next-gen delivery catheter with enhanced steerability"},
    ]
  },
  {
    name:"Labeling Expansions", icon:"üìã", color:"#FF6B35", count:28, pct:13,
    sig:"High ‚Äî authorized claims", burden:"High ‚Äî clinical data required",
    suppType:"Panel Track / 180-Day",
    desc:"New or expanded indications, MRI conditionality expansions, IFU updates, patient population expansions, safety communications.",
    examples:[
      {supp:"S001",           date:"2016",      detail:"Initial post-approval labeling clarifications ‚Äî IFU refinements"},
      {supp:"~S018‚ÄìS022",     date:"2017",      detail:"MRI conditionality labeling update (1.5T/3T full-body MRI)"},
      {supp:"S061",           date:"Jan 2020",  detail:"Micra AV label: new VDD pacing indication for AV block patients"},
      {supp:"~S095‚ÄìS105",     date:"2021",      detail:"Cardiac perforation/tamponade risk communication; updated warnings"},
      {supp:"~S145‚ÄìS155",     date:"2023",      detail:"Micra AV2/VR2 labeling; 40% battery life claim; >80% device-for-life"},
    ]
  },
  {
    name:"Design Changes / New Models", icon:"üî¨", color:"#FF1744", count:25, pct:12,
    sig:"Very High ‚Äî new patient populations", burden:"Very High ‚Äî panel track",
    suppType:"Panel Track / 180-Day",
    desc:"Hardware platform changes, new device models, battery chemistry, fixation tine redesigns ‚Äî includes the two major Panel Track supplements (Micra AV & AV2).",
    examples:[
      {supp:"~S008‚ÄìS015",     date:"2016‚Äì2017", detail:"Gen 1 post-launch design refinements from early clinical registry"},
      {supp:"~S035‚ÄìS050",     date:"2018‚Äì2019", detail:"Structural design optimization ‚Äî tine geometry, MCRD drug-eluting"},
      {supp:"S061 (Panel)",   date:"Jan 2020",  detail:"Micra AV (MC1AVR1) ‚Äî new accelerometer-based AV sensing platform"},
      {supp:"~S120‚ÄìS135",     date:"2022",      detail:"Battery chemistry change supporting extended longevity AV2/VR2"},
      {supp:"~S140‚ÄìS152",     date:"May 2023",  detail:"Micra AV2 & VR2 ‚Äî 2nd gen hardware, 40% more battery"},
    ]
  },
];

const TOTAL = 217;
let selCat  = null;   // for Section 1 highlight
let expanded = null;  // for Section 3 expand

let liveSupps  = [];
let liveLoaded = false;
let s4Filter   = null;

// ‚îÄ‚îÄ Section 1 toggle (KPIs + chart highlight) ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
function toggleChart(i) {
  selCat = selCat === i ? null : i;
  renderKPIs();
  renderChart();
  renderDetailPanel();
}

// ‚îÄ‚îÄ Section 3 toggle (expand row) ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
function toggleExpand(i) {
  expanded = expanded === i ? null : i;
  renderSummaryTable();
  if (expanded !== null) {
    setTimeout(() => {
      const el = document.getElementById(`exp-row-${i}`);
      if (el) el.scrollIntoView({behavior:'smooth', block:'nearest'});
    }, 50);
  }
}

// ‚îÄ‚îÄ Section 4 filter ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
function setS4Filter(i) {
  s4Filter = s4Filter === i ? null : i;
  renderSuppTable();
}

function badgeStyle(t) {
  if (!t) return 'background:#1a1a1a;color:#64748b';
  const u = t.toUpperCase();
  if (/PANEL/.test(u))      return 'background:#1a0044;color:#CC33FF';
  if (/180/.test(u))        return 'background:#0a0a2a;color:#00D4FF';
  if (/30|REAL/.test(u))    return 'background:#001a0a;color:#00E676';
  if (/LABEL/.test(u))      return 'background:#1a0800;color:#FF6B00';
  if (/SPECIAL/.test(u))    return 'background:#001a0a;color:#2dd4bf';
  return 'background:#1a1a1a;color:#64748b';
}

// ‚îÄ‚îÄ Render KPIs ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
function renderKPIs() {
  document.getElementById('kpiGrid').innerHTML = CATS.map((c, i) =>
    `<button class="kpi-card" style="${selCat===i?`background:${c.color}22;border-color:${c.color}`:'border-color:#1a1a1a'}" onclick="toggleChart(${i})">
      <div class="kpi-icon">${c.icon}</div>
      <div class="kpi-count" style="color:${c.color}">${c.count}</div>
      <div class="kpi-pct">${c.pct}% of total</div>
      <div class="kpi-name">${c.name}</div>
    </button>`).join('');
}

// ‚îÄ‚îÄ Render Chart ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
function renderChart() {
  const maxCnt = Math.max(...CATS.map(c=>c.count));
  document.getElementById('chartLabel').textContent = `SUPPLEMENT VOLUME BY CATEGORY ‚Äî TOTAL: ${TOTAL}`;
  document.getElementById('barChart').innerHTML = CATS.map((c, i) => {
    const wPct = ((c.count/maxCnt)*100).toFixed(1);
    const op = selCat===null||selCat===i ? 1 : 0.18;
    const dimStyle = op < 1 ? 'opacity:'+op : '';
    const selClass = (selCat===i) ? ' selected' : '';
    const colorRgb = c.color.replace('#','');
    const r=parseInt(colorRgb.substr(0,2),16),g=parseInt(colorRgb.substr(2,2),16),b=parseInt(colorRgb.substr(4,2),16);
    const shortName = c.name.replace(' / Algorithm Updates','').replace(' & Delivery System','').replace(' Changes','').replace(' Expansions','');
    return `<div class="bar-col${selClass}" onclick="toggleChart(${i})" style="${dimStyle}">
      <div class="bar-label-col" style="after-background:${c.color}">
        <div style="position:absolute;right:-1px;top:25%;height:50%;width:2px;background:${c.color};opacity:.45;border-radius:1px"></div>
        <div style="font-family:monospace;font-size:9px;color:#444;letter-spacing:.15em;margin-bottom:4px">CAT 0${i+1}</div>
        <div class="bar-name">${c.icon} ${shortName}</div>
        <div class="bar-sub">${c.suppType}</div>
      </div>
      <div class="bar-track-col">
        <div class="bar-track">
          <div class="bar-h" data-w="${wPct}%" style="background:linear-gradient(90deg,rgba(${r},${g},${b},.12),${c.color});box-shadow:0 0 10px rgba(${r},${g},${b},.25)">
            <div class="bar-bubble" style="color:${c.color};border-color:${c.color};box-shadow:0 0 6px rgba(${r},${g},${b},.3)">${c.count} <span style="font-size:9px;opacity:.6">(${c.pct}%)</span></div>
          </div>
        </div>
        <div class="bar-pct" style="margin-left:4px;color:${c.color};opacity:.4">${c.sig}</div>
      </div>
    </div>`;
  }).join('');
  // animate bars
  requestAnimationFrame(() => {
    document.querySelectorAll('#barChart .bar-h').forEach((b,i) => {
      b.style.width = '0';
      setTimeout(() => { b.style.width = b.getAttribute('data-w'); }, 80 + i*120);
    });
  });
}

// ‚îÄ‚îÄ Render top detail panel ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
function renderDetailPanel() {
  const dp = document.getElementById('detailPanel');
  if (selCat===null){dp.innerHTML='';return;}
  const c = CATS[selCat];
  dp.innerHTML = `
    <div class="detail-panel" style="background:#0f0f0f;border:1px solid ${c.color}55;margin-bottom:32px">
      <div class="d-hdr">
        <span class="d-icon">${c.icon}</span>
        <div><div class="d-title" style="color:${c.color}">${c.name}</div>
        <div class="d-type">Supplement Type: ${c.suppType}</div></div>
        <div style="margin-left:auto;text-align:right">
          <div class="d-count" style="color:${c.color}">${c.count}</div>
          <div class="d-pct">${c.pct}% of ${TOTAL}</div>
        </div>
      </div>
      <p class="d-desc">${c.desc}</p>
      <div style="font-size:11px;color:#475569;font-family:monospace">‚Üì Click this category in Section 3 below for full expandable supplement list</div>
    </div>`;
}

// ‚îÄ‚îÄ Render Section 3 expandable summary ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
function renderSummaryTable() {
  let html = '';
  CATS.forEach((c, i) => {
    const isOpen   = expanded === i;
    const rowBg    = isOpen ? c.color+'18' : i%2===0 ? 'transparent' : '#111111';
    const arrowCls = isOpen ? 'expand-arrow open' : 'expand-arrow';

    // Main summary row
    html += `<tr class="sum-row" style="background:${rowBg};border-bottom:${isOpen?'none':'1px solid #1a1a1a'}" onclick="toggleExpand(${i})">
      <td class="s-td" style="width:32px"><span class="${arrowCls}">‚ñ∂</span></td>
      <td class="s-td" style="color:${c.color};font-weight:700">${i+1}</td>
      <td class="s-td"><span style="font-size:15px;margin-right:8px">${c.icon}</span><span style="color:#f1f5f9;font-weight:600">${c.name}</span></td>
      <td class="s-td" style="color:#94a3b8;font-size:11px;font-family:monospace">${c.suppType}</td>
      <td class="s-td" style="color:${c.color};font-weight:700;font-size:20px">${c.count}</td>
      <td class="s-td">
        <div class="prog-wrap">
          <div class="prog-track"><div class="prog-fill" style="width:${c.pct}%;background:${c.color}"></div></div>
          <span style="color:#94a3b8;font-size:12px">${c.pct}%</span>
        </div>
      </td>
      <td class="s-td" style="color:#94a3b8;font-size:12px">${c.sig}</td>
      <td class="s-td" style="color:#94a3b8;font-size:12px">${c.burden}</td>
    </tr>`;

    // Expandable row
    html += `<tr id="exp-row-${i}" class="expand-row ${isOpen?'open':''}">
      <td colspan="8" class="expand-inner">
        <div class="exp-box" style="border-left:3px solid ${c.color}">

          <!-- Header -->
          <div class="exp-header">
            <span style="font-size:28px">${c.icon}</span>
            <div>
              <div style="font-size:16px;font-weight:700;color:${c.color}">${c.name}</div>
              <div style="font-size:11px;color:#64748b;margin-top:2px">Supplement Type: ${c.suppType} ¬∑ Regulatory Burden: ${c.burden}</div>
            </div>
            <div style="margin-left:auto;background:${c.color};color:#fff;border-radius:8px;padding:6px 18px;text-align:center">
              <div style="font-size:28px;font-weight:700;line-height:1">${c.count}</div>
              <div style="font-size:10px;letter-spacing:.1em">SUPPLEMENTS</div>
            </div>
          </div>

          <!-- Description -->
          <p class="exp-desc">${c.desc}</p>

          <!-- Representative examples table -->
          <div style="font-size:10px;letter-spacing:.15em;text-transform:uppercase;font-family:monospace;color:#334155;margin-bottom:8px">Representative Supplement Examples</div>
          <div style="overflow-x:auto;margin-bottom:20px">
            <table class="exp-table" style="background:#050505;border:1px solid #111111;border-radius:6px">
              <thead>
                <tr>
                  <th>Supplement(s)</th>
                  <th>Date Range</th>
                  <th>Change Description</th>
                </tr>
              </thead>
              <tbody>
                ${c.examples.map((ex,ei) => `
                  <tr style="background:${ei%2===0?'transparent':'#050505'}">
                    <td style="color:${c.color};font-family:monospace;font-weight:600;white-space:nowrap">${ex.supp}</td>
                    <td style="color:#94a3b8;white-space:nowrap">${ex.date}</td>
                    <td style="color:#cbd5e1">${ex.detail}</td>
                  </tr>`).join('')}
              </tbody>
            </table>
          </div>

          <!-- Live FDA data sub-section -->
          <div class="live-sub">
            <div class="live-sub-lbl">üì° Live FDA Supplement Records (openFDA) ‚Äî Supplement Type Matches</div>
            ${renderLiveSubTable(i, c)}
          </div>

          <!-- Close button -->
          <div style="margin-top:16px;text-align:right">
            <button onclick="toggleExpand(${i})" style="background:#0f0f0f;border:1px solid #1a1a1a;color:#64748b;padding:6px 16px;border-radius:6px;font-size:11px;font-family:monospace;cursor:pointer">‚ñ≤ Collapse</button>
          </div>
        </div>
      </td>
    </tr>`;
  });

  // Total row
  html += `<tr style="border-top:2px solid #2D0066;background:#111111">
    <td colspan="4" class="s-td" style="color:#A100FF;font-weight:700;text-transform:uppercase;font-size:11px;letter-spacing:.1em">TOTAL</td>
    <td class="s-td" style="color:#A100FF;font-weight:700;font-size:20px">${TOTAL}</td>
    <td class="s-td" style="color:#A100FF;font-weight:700">100%</td>
    <td colspan="2" class="s-td" style="color:#475569;font-size:11px">Source: FDA PMA Database P150033 ¬∑ 2016‚Äì2026</td>
  </tr>`;

  document.getElementById('summaryBody').innerHTML = html;
}

// Returns HTML for the live FDA sub-table inside each expanded row
function renderLiveSubTable(catIdx, c) {
  if (!liveLoaded) return `<div class="live-status"><span class="spinner"></span>Loading live FDA data‚Ä¶</div>`;
  if (!liveSupps.length) return `<div class="live-status" style="color:#7f1d1d">Live data unavailable ‚Äî check network connection</div>`;

  // Type filters per category
  const typeFilters = [
    /30.DAY|REAL.?TIME|MANUFACTURING/i,
    /180.DAY|SOFTWARE/i,
    /SPECIAL/i,
    /LABEL/i,
    /PANEL/i,
  ];
  const matched = liveSupps.filter(s => typeFilters[catIdx].test(s.supplement_type||''));

  if (!matched.length) {
    return `<div class="live-status">No exact supplement type matches in live FDA data ‚Äî see Section 4 for full unfiltered list.<br>
      <span style="color:#334155;font-size:10px">Note: FDA API supplement_type field uses standardized codes that may not directly map to category labels.</span></div>`;
  }

  return `<div style="overflow-x:auto">
    <table class="exp-table" style="background:#050505;border:1px solid #111111;border-radius:6px">
      <thead><tr>
        <th>Supplement #</th><th>Decision Date</th><th>Supplement Type</th><th>Trade Name</th><th>Link</th>
      </tr></thead>
      <tbody>
        ${matched.map((s,i) => {
          const snum  = s.supplement_number||'‚Äî';
          const pnum  = s.pma_number||'P150033';
          const stype = s.supplement_type||'‚Äî';
          const ddate = s.decision_date ? new Date(s.decision_date).toLocaleDateString('en-US',{year:'numeric',month:'short',day:'numeric'}) : '‚Äî';
          const tname = s.trade_name||s.generic_name||'Micra‚Ñ¢ TPS';
          const href  = `https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=${pnum}${snum}`;
          return `<tr style="background:${i%2===0?'transparent':'#050505'}">
            <td style="color:${c.color};font-family:monospace;font-weight:600;white-space:nowrap">${snum}</td>
            <td style="color:#94a3b8;white-space:nowrap">${ddate}</td>
            <td><span class="badge" style="${badgeStyle(stype)}">${stype}</span></td>
            <td style="color:#cbd5e1;max-width:220px">${tname}</td>
            <td><a href="${href}" target="_blank" style="color:#334155;font-size:10px;font-family:monospace">‚Üó VIEW</a></td>
          </tr>`;
        }).join('')}
      </tbody>
    </table>
    <div style="font-size:10px;color:#334155;font-family:monospace;margin-top:6px">${matched.length} records matched by supplement type ¬∑ Full list in Section 4</div>
  </div>`;
}

// ‚îÄ‚îÄ Render Section 4 ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
function renderSuppTable() {
  const items = s4Filter!==null ? liveSupps.filter(s => {
    const filters = [/30.DAY|REAL.?TIME|MANUFACTURING/i,/180.DAY|SOFTWARE/i,/SPECIAL/i,/LABEL/i,/PANEL/i];
    return filters[s4Filter].test(s.supplement_type||'');
  }) : liveSupps;

  const c = s4Filter!==null ? CATS[s4Filter] : null;
  document.getElementById('suppLabel').textContent =
    s4Filter!==null ? `SECTION 4 ¬∑ ${c.icon} ${c.name} ‚Äî ${items.length} Records`
                    : `SECTION 4 ¬∑ All ${liveSupps.length} Approved Supplements ‚Äî Live from openFDA`;

  document.getElementById('filterBtns').innerHTML =
    `<button class="fbtn" onclick="setS4Filter(null)" style="${s4Filter===null?'background:#2D0066;color:#A100FF;border:1px solid #A100FF':'background:#0f0f0f;color:#64748b;border:1px solid #1a1a1a'}">ALL (${liveSupps.length})</button>` +
    CATS.map((ct,i) => `<button class="fbtn" onclick="setS4Filter(${i})" style="${s4Filter===i?`background:${ct.color}22;color:${ct.color};border:1px solid ${ct.color}`:'background:#0f0f0f;color:#64748b;border:1px solid #1a1a1a'}">${ct.icon} ${ct.name}</button>`).join('');

  document.getElementById('suppHead').innerHTML =
    ['Supplement #','Decision Date','Supplement Type','Device / Trade Name','FDA Record']
    .map(h=>`<th>${h}</th>`).join('');

  if (!liveLoaded) return;

  const color = c ? c.color : '#A100FF';
  document.getElementById('suppBody').innerHTML = !items.length
    ? `<tr><td colspan="5" style="padding:20px;text-align:center;color:#475569;font-family:monospace">No records found</td></tr>`
    : items.map((s,i) => {
        const snum  = s.supplement_number||'‚Äî';
        const pnum  = s.pma_number||'P150033';
        const stype = s.supplement_type||'‚Äî';
        const ddate = s.decision_date ? new Date(s.decision_date).toLocaleDateString('en-US',{year:'numeric',month:'short',day:'numeric'}) : '‚Äî';
        const tname = s.trade_name||s.generic_name||'Micra‚Ñ¢ TPS';
        const href  = `https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=${pnum}${snum}`;
        return `<tr style="background:${i%2===0?'transparent':'#111111'};border-bottom:1px solid #111111">
          <td style="color:${color};font-family:monospace;font-weight:600;white-space:nowrap">${snum}</td>
          <td style="color:#94a3b8;white-space:nowrap">${ddate}</td>
          <td><span class="badge" style="${badgeStyle(stype)}">${stype}</span></td>
          <td style="color:#cbd5e1;max-width:280px">${tname}</td>
          <td><a href="${href}" target="_blank" style="color:#334155;font-size:10px;font-family:monospace">‚Üó VIEW</a></td>
        </tr>`;
      }).join('');
}

// ‚îÄ‚îÄ Boot ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
renderKPIs();
renderChart();
renderSummaryTable();
renderSuppTable();

async function fetchLive() {
  let out=[], skip=0;
  while(true){
    const r = await fetch(`https://api.fda.gov/device/pma.json?search=pma_number:P150033&limit=100&skip=${skip}`);
    if(!r.ok){if(skip===0)throw new Error(`openFDA ${r.status}`);break;}
    const j = await r.json();
    const hits = j.results||[];
    out = out.concat(hits);
    if(hits.length<100) break;
    skip+=100;
  }
  return out.filter(r=>r.supplement_number&&r.supplement_number.trim())
            .sort((a,b)=>{
              const n=x=>parseInt((x.supplement_number||'').replace(/\D/g,''))||0;
              return n(a)-n(b);
            });
}

fetchLive().then(data => {
  liveSupps  = data;
  liveLoaded = true;
  // Re-render Section 3 expanded row if open, and Section 4
  if (expanded !== null) renderSummaryTable();
  renderSuppTable();
}).catch(e => {
  liveLoaded = true;
  document.getElementById('errorMsg').style.display = 'block';
  document.getElementById('errorMsg').innerHTML =
    `<strong>‚ö† Live supplement list unavailable:</strong> ${e.message} ‚Äî
     <a href="https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=p150033" target="_blank">View directly on FDA.gov</a>`;
  renderSuppTable();
});

// ‚îÄ‚îÄ HCC Bar Animation ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
function animateHCCBars() {
  const fills = document.querySelectorAll('.hcc-fill, .svc-bar');
  // Vertical bars
  const vbars = document.querySelectorAll('.vbar-fill');
  vbars.forEach(b => { b.style.height = '0'; });
  setTimeout(() => {
    vbars.forEach((b, i) => {
      setTimeout(() => {
        b.style.height = b.getAttribute('data-h') || '0%';
      }, i * 60);
    });
  }, 400);
  fills.forEach((bar, i) => {
    const target = bar.getAttribute('data-w') || '0%';
    bar.style.width = '0';
    setTimeout(() => {
      bar.style.transition = 'width 1.1s cubic-bezier(.16,1,.3,1)';
      bar.style.width = target;
    }, 300 + i * 130);
  });
}

// Observe competitor tab activation to trigger animation
const origSwitch = window.switchTab;
window.switchTab = function(tab, btn) {
  origSwitch(tab, btn);

  if (tab === 'micra') {
    // Re-run renderChart so bars animate in fresh
    setTimeout(() => { renderChart(); }, 80);
  }

  if (tab === 'competitor') setTimeout(animateHCCBars, 100);

  if (tab === 'predict') setTimeout(() => {
    // Failure mode bars
    document.querySelectorAll('.fail-bar').forEach(b => {
      b.style.width = '0';
      setTimeout(() => { b.style.width = b.getAttribute('data-w') || '0%'; }, 600);
    });
    // Horizontal prediction bars
    document.querySelectorAll('.pred-bar').forEach(b => {
      b.style.width = '0';
      setTimeout(() => { b.style.width = b.getAttribute('data-w') || '0%'; }, 150);
    });
    // Vertical forecast bars
    document.querySelectorAll('.fc-bar').forEach(b => {
      b.style.height = '0';
      setTimeout(() => { b.style.height = b.getAttribute('data-h') || '0%'; }, 200);
    });
    // Arc gauge circles ‚Äî animate stroke-dashoffset from full (150.8) to target
    const circ = 150.8;
    document.querySelectorAll('.conf-arc').forEach((arc, i) => {
      const target = parseFloat(arc.getAttribute('data-offset'));
      arc.style.transition = 'none';
      arc.style.strokeDashoffset = circ; // start empty
      setTimeout(() => {
        arc.style.transition = 'stroke-dashoffset 1.2s cubic-bezier(.16,1,.3,1)';
        arc.style.strokeDashoffset = target;
      }, 300 + i * 150);
    });
  }, 100);
};
</script>
</body>
</html>
